| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Crohn Disease | 99 | 2024 | 2279 | 9.280 |
Why?
|
| Inflammatory Bowel Diseases | 87 | 2024 | 2422 | 8.720 |
Why?
|
| Autophagy | 67 | 2023 | 1327 | 7.360 |
Why?
|
| Colitis, Ulcerative | 48 | 2024 | 1922 | 4.180 |
Why?
|
| Bacteria | 38 | 2024 | 2199 | 4.010 |
Why?
|
| CARD Signaling Adaptor Proteins | 18 | 2024 | 159 | 4.010 |
Why?
|
| Intestinal Mucosa | 52 | 2024 | 3032 | 3.630 |
Why?
|
| Feces | 41 | 2024 | 1497 | 2.820 |
Why?
|
| Cytokines | 51 | 2024 | 7396 | 2.760 |
Why?
|
| Bacteroides | 8 | 2021 | 165 | 2.590 |
Why?
|
| Intestines | 28 | 2024 | 1910 | 2.570 |
Why?
|
| Colitis | 25 | 2024 | 1233 | 2.540 |
Why?
|
| Carrier Proteins | 32 | 2021 | 4937 | 2.380 |
Why?
|
| Immunity, Innate | 40 | 2023 | 3066 | 2.380 |
Why?
|
| Gastrointestinal Tract | 17 | 2023 | 833 | 2.260 |
Why?
|
| Inflammation | 49 | 2024 | 10774 | 2.200 |
Why?
|
| Th17 Cells | 16 | 2022 | 794 | 2.190 |
Why?
|
| BCG Vaccine | 10 | 2021 | 369 | 2.080 |
Why?
|
| Lysosomes | 16 | 2022 | 924 | 1.890 |
Why?
|
| Symbiosis | 8 | 2024 | 294 | 1.790 |
Why?
|
| Mice | 198 | 2024 | 81539 | 1.780 |
Why?
|
| Homeostasis | 23 | 2023 | 3323 | 1.680 |
Why?
|
| Ubiquitin-Protein Ligases | 12 | 2023 | 1899 | 1.670 |
Why?
|
| Receptors, G-Protein-Coupled | 8 | 2024 | 1252 | 1.650 |
Why?
|
| Animals | 252 | 2024 | 168475 | 1.650 |
Why?
|
| Salmonella Infections | 6 | 2017 | 172 | 1.590 |
Why?
|
| Salmonella | 7 | 2021 | 125 | 1.570 |
Why?
|
| RNA, Ribosomal, 16S | 15 | 2024 | 1039 | 1.570 |
Why?
|
| Salmonella typhimurium | 9 | 2016 | 347 | 1.560 |
Why?
|
| Signal Transduction | 72 | 2024 | 23447 | 1.490 |
Why?
|
| Metagenomics | 20 | 2022 | 467 | 1.470 |
Why?
|
| Small Molecule Libraries | 5 | 2017 | 733 | 1.440 |
Why?
|
| Unfolded Protein Response | 4 | 2021 | 234 | 1.400 |
Why?
|
| Host-Pathogen Interactions | 18 | 2019 | 1459 | 1.360 |
Why?
|
| Adaptor Proteins, Signal Transducing | 22 | 2020 | 2898 | 1.350 |
Why?
|
| Epithelial Cells | 19 | 2024 | 3677 | 1.350 |
Why?
|
| Lectins, C-Type | 6 | 2020 | 585 | 1.340 |
Why?
|
| Immune System | 9 | 2023 | 796 | 1.310 |
Why?
|
| Nod2 Signaling Adaptor Protein | 13 | 2019 | 86 | 1.290 |
Why?
|
| Metagenome | 18 | 2024 | 450 | 1.290 |
Why?
|
| Humans | 428 | 2024 | 761578 | 1.280 |
Why?
|
| Enterobacteriaceae Infections | 7 | 2024 | 188 | 1.250 |
Why?
|
| T-Lymphocytes | 28 | 2021 | 10194 | 1.200 |
Why?
|
| Gene Expression Regulation | 30 | 2023 | 11904 | 1.180 |
Why?
|
| Genome, Bacterial | 9 | 2021 | 783 | 1.170 |
Why?
|
| Genetic Predisposition to Disease | 56 | 2024 | 17904 | 1.170 |
Why?
|
| Genetic Variation | 13 | 2021 | 6567 | 1.150 |
Why?
|
| Adaptive Immunity | 10 | 2021 | 726 | 1.150 |
Why?
|
| Cation Transport Proteins | 5 | 2022 | 327 | 1.140 |
Why?
|
| Diabetes Mellitus, Type 1 | 8 | 2022 | 3415 | 1.130 |
Why?
|
| Paneth Cells | 10 | 2018 | 98 | 1.120 |
Why?
|
| Th1 Cells | 10 | 2023 | 1036 | 1.100 |
Why?
|
| Phagocytes | 3 | 2018 | 295 | 1.100 |
Why?
|
| Interleukin-10 | 10 | 2022 | 1175 | 1.070 |
Why?
|
| HeLa Cells | 21 | 2021 | 3094 | 1.060 |
Why?
|
| Microtubule-Associated Proteins | 17 | 2018 | 1076 | 1.050 |
Why?
|
| Escherichia coli Infections | 3 | 2023 | 518 | 1.050 |
Why?
|
| Citrobacter rodentium | 6 | 2022 | 65 | 1.040 |
Why?
|
| Immune System Diseases | 5 | 2020 | 256 | 1.020 |
Why?
|
| Macrophages | 32 | 2023 | 5767 | 1.010 |
Why?
|
| Mice, Inbred C57BL | 67 | 2024 | 22173 | 1.000 |
Why?
|
| Cholesterol | 7 | 2024 | 2905 | 0.960 |
Why?
|
| Gene Expression Profiling | 39 | 2024 | 9420 | 0.950 |
Why?
|
| NF-kappa B | 20 | 2019 | 2490 | 0.950 |
Why?
|
| Membrane Proteins | 25 | 2020 | 7859 | 0.940 |
Why?
|
| Dendritic Cells | 15 | 2024 | 2747 | 0.930 |
Why?
|
| Immune Tolerance | 8 | 2024 | 2302 | 0.910 |
Why?
|
| Polymorphism, Single Nucleotide | 44 | 2024 | 15936 | 0.900 |
Why?
|
| Agaricales | 1 | 2023 | 30 | 0.900 |
Why?
|
| Lymphocytes | 8 | 2023 | 2612 | 0.880 |
Why?
|
| Genome-Wide Association Study | 35 | 2024 | 12690 | 0.880 |
Why?
|
| Mice, Knockout | 53 | 2020 | 14417 | 0.880 |
Why?
|
| Colon | 18 | 2023 | 1792 | 0.880 |
Why?
|
| B-Lymphocytes | 9 | 2024 | 4758 | 0.870 |
Why?
|
| Quantitative Trait Loci | 11 | 2023 | 2116 | 0.850 |
Why?
|
| Veillonella | 1 | 2022 | 21 | 0.840 |
Why?
|
| Immunologic Memory | 8 | 2021 | 1359 | 0.840 |
Why?
|
| Monocytes | 12 | 2021 | 2570 | 0.840 |
Why?
|
| Metabolomics | 13 | 2024 | 1659 | 0.830 |
Why?
|
| Immunity | 8 | 2022 | 996 | 0.830 |
Why?
|
| Salmonella enterica | 3 | 2018 | 76 | 0.830 |
Why?
|
| Cell Differentiation | 22 | 2024 | 11530 | 0.820 |
Why?
|
| Apoptosis Regulatory Proteins | 10 | 2018 | 1136 | 0.820 |
Why?
|
| T-Lymphocytes, Regulatory | 10 | 2021 | 3080 | 0.810 |
Why?
|
| Biological Therapy | 3 | 2021 | 141 | 0.810 |
Why?
|
| 1-Phosphatidylinositol 4-Kinase | 1 | 2021 | 59 | 0.790 |
Why?
|
| CD4-Positive T-Lymphocytes | 12 | 2024 | 4369 | 0.790 |
Why?
|
| Autoimmunity | 6 | 2024 | 1356 | 0.780 |
Why?
|
| Cyclin-Dependent Kinase 8 | 2 | 2021 | 48 | 0.780 |
Why?
|
| Probiotics | 5 | 2024 | 378 | 0.780 |
Why?
|
| Neuropeptides | 5 | 2019 | 944 | 0.780 |
Why?
|
| Immunodominant Epitopes | 2 | 2022 | 239 | 0.780 |
Why?
|
| Candida albicans | 10 | 2019 | 372 | 0.770 |
Why?
|
| Phosphoric Monoester Hydrolases | 2 | 2021 | 412 | 0.770 |
Why?
|
| GTP-Binding Proteins | 7 | 2018 | 951 | 0.770 |
Why?
|
| Metabolic Networks and Pathways | 6 | 2021 | 789 | 0.770 |
Why?
|
| Immunity, Mucosal | 6 | 2020 | 483 | 0.760 |
Why?
|
| ADP Ribose Transferases | 1 | 2021 | 90 | 0.760 |
Why?
|
| Ileum | 9 | 2023 | 557 | 0.760 |
Why?
|
| Interleukin-1beta | 16 | 2019 | 999 | 0.750 |
Why?
|
| Genomics | 15 | 2021 | 5821 | 0.740 |
Why?
|
| DNA, Bacterial | 6 | 2021 | 1479 | 0.740 |
Why?
|
| Eosinophilic Esophagitis | 1 | 2024 | 197 | 0.730 |
Why?
|
| Inosine | 1 | 2021 | 130 | 0.730 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 2 | 2020 | 318 | 0.730 |
Why?
|
| Cholestanol | 1 | 2020 | 5 | 0.730 |
Why?
|
| Polyendocrinopathies, Autoimmune | 1 | 2021 | 56 | 0.720 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2021 | 201 | 0.720 |
Why?
|
| Phosphoproteins | 5 | 2018 | 2448 | 0.720 |
Why?
|
| Mycoses | 1 | 2024 | 386 | 0.720 |
Why?
|
| Scleroderma, Systemic | 2 | 2023 | 344 | 0.720 |
Why?
|
| Enteritis | 3 | 2021 | 162 | 0.720 |
Why?
|
| Genotype | 24 | 2024 | 12990 | 0.710 |
Why?
|
| Single-Cell Analysis | 11 | 2024 | 2451 | 0.710 |
Why?
|
| Enteropathogenic Escherichia coli | 2 | 2011 | 26 | 0.710 |
Why?
|
| Calcitonin Gene-Related Peptide | 2 | 2019 | 323 | 0.690 |
Why?
|
| Phenotype | 35 | 2024 | 16592 | 0.680 |
Why?
|
| Molecular Probes | 2 | 2024 | 309 | 0.680 |
Why?
|
| HEK293 Cells | 16 | 2021 | 4281 | 0.670 |
Why?
|
| Cells, Cultured | 40 | 2021 | 18966 | 0.660 |
Why?
|
| Ethanolamines | 1 | 2020 | 153 | 0.660 |
Why?
|
| Epithelium | 4 | 2017 | 1603 | 0.660 |
Why?
|
| Sequence Analysis, RNA | 9 | 2024 | 2021 | 0.650 |
Why?
|
| Bacteroidetes | 5 | 2023 | 84 | 0.640 |
Why?
|
| Gastrointestinal Agents | 5 | 2018 | 510 | 0.640 |
Why?
|
| Manganese | 2 | 2022 | 393 | 0.630 |
Why?
|
| Drug Resistance, Bacterial | 5 | 2024 | 1048 | 0.630 |
Why?
|
| Oxidoreductases | 2 | 2020 | 413 | 0.630 |
Why?
|
| Proteins | 11 | 2023 | 6032 | 0.620 |
Why?
|
| Niemann-Pick Disease, Type C | 2 | 2016 | 49 | 0.620 |
Why?
|
| Immunity, Cellular | 5 | 2020 | 1560 | 0.620 |
Why?
|
| DNA, Intergenic | 1 | 2019 | 105 | 0.620 |
Why?
|
| Peroxiredoxins | 1 | 2018 | 51 | 0.610 |
Why?
|
| Mycobacterium tuberculosis | 6 | 2023 | 1914 | 0.600 |
Why?
|
| Cell Line | 40 | 2021 | 15601 | 0.600 |
Why?
|
| Polymorphism, Genetic | 7 | 2020 | 4243 | 0.600 |
Why?
|
| Bacteriophages | 4 | 2023 | 378 | 0.600 |
Why?
|
| Bile Acids and Salts | 5 | 2024 | 393 | 0.590 |
Why?
|
| Interferon-gamma | 15 | 2019 | 3162 | 0.590 |
Why?
|
| Peptostreptococcus | 1 | 2017 | 29 | 0.590 |
Why?
|
| Sphingolipids | 1 | 2019 | 174 | 0.580 |
Why?
|
| Guanine Nucleotide Exchange Factors | 3 | 2018 | 569 | 0.580 |
Why?
|
| Adherens Junctions | 1 | 2018 | 89 | 0.580 |
Why?
|
| Tumor Necrosis Factor-alpha | 21 | 2023 | 4352 | 0.580 |
Why?
|
| Mother-Child Relations | 2 | 2018 | 495 | 0.580 |
Why?
|
| Histocompatibility Antigens Class II | 2 | 2018 | 1435 | 0.580 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 8 | 2018 | 3810 | 0.570 |
Why?
|
| DNA-Binding Proteins | 10 | 2021 | 9610 | 0.570 |
Why?
|
| Metabolome | 8 | 2024 | 989 | 0.570 |
Why?
|
| Respiratory Burst | 2 | 2015 | 110 | 0.560 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 3 | 2024 | 1136 | 0.560 |
Why?
|
| Guanylate Cyclase | 3 | 2006 | 205 | 0.560 |
Why?
|
| Salmonella Infections, Animal | 2 | 2014 | 60 | 0.560 |
Why?
|
| Hexosyltransferases | 1 | 2016 | 58 | 0.550 |
Why?
|
| Sequence Analysis, DNA | 11 | 2021 | 4740 | 0.550 |
Why?
|
| Mutation, Missense | 7 | 2020 | 2571 | 0.550 |
Why?
|
| Intestinal Diseases | 2 | 2020 | 504 | 0.540 |
Why?
|
| Microfilament Proteins | 5 | 2017 | 1134 | 0.540 |
Why?
|
| RNA, Small Interfering | 21 | 2020 | 3430 | 0.540 |
Why?
|
| Ubiquitination | 9 | 2020 | 1007 | 0.530 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 3 | 2019 | 974 | 0.530 |
Why?
|
| Health | 2 | 2019 | 398 | 0.520 |
Why?
|
| Transcription, Genetic | 16 | 2022 | 7593 | 0.520 |
Why?
|
| Germ-Free Life | 7 | 2021 | 189 | 0.520 |
Why?
|
| Receptors, Endothelin | 1 | 2015 | 56 | 0.510 |
Why?
|
| Computational Biology | 11 | 2021 | 3517 | 0.510 |
Why?
|
| Candidiasis, Invasive | 1 | 2015 | 23 | 0.510 |
Why?
|
| Receptors, Mitogen | 1 | 2015 | 61 | 0.500 |
Why?
|
| Phagosomes | 5 | 2019 | 199 | 0.500 |
Why?
|
| Receptors, Angiotensin | 1 | 2015 | 141 | 0.500 |
Why?
|
| Disease Models, Animal | 25 | 2020 | 18255 | 0.500 |
Why?
|
| Male | 131 | 2024 | 360841 | 0.490 |
Why?
|
| Anti-Bacterial Agents | 10 | 2022 | 7406 | 0.490 |
Why?
|
| Receptors, Antigen, T-Cell | 12 | 2018 | 2547 | 0.490 |
Why?
|
| Female | 132 | 2024 | 392688 | 0.490 |
Why?
|
| Plasma Cells | 2 | 2023 | 599 | 0.490 |
Why?
|
| Organ Specificity | 5 | 2021 | 1968 | 0.490 |
Why?
|
| Antigen Presentation | 3 | 2018 | 1251 | 0.490 |
Why?
|
| Influenza Vaccines | 1 | 2022 | 768 | 0.480 |
Why?
|
| Urban Population | 3 | 2021 | 2036 | 0.480 |
Why?
|
| Serum Response Element | 2 | 2004 | 7 | 0.480 |
Why?
|
| Organoids | 5 | 2023 | 746 | 0.470 |
Why?
|
| Protein Binding | 19 | 2020 | 9353 | 0.470 |
Why?
|
| Homeodomain Proteins | 5 | 2020 | 2418 | 0.470 |
Why?
|
| Th2 Cells | 8 | 2019 | 1060 | 0.470 |
Why?
|
| Genome, Human | 13 | 2024 | 4425 | 0.460 |
Why?
|
| Celiac Disease | 5 | 2023 | 821 | 0.460 |
Why?
|
| Cohort Studies | 34 | 2024 | 41493 | 0.460 |
Why?
|
| Gene Knock-In Techniques | 5 | 2020 | 421 | 0.460 |
Why?
|
| Protein-Tyrosine Kinases | 7 | 2017 | 2425 | 0.460 |
Why?
|
| Interferon Type I | 4 | 2017 | 562 | 0.450 |
Why?
|
| Adaptation, Physiological | 2 | 2018 | 1301 | 0.450 |
Why?
|
| Immunologic Factors | 4 | 2019 | 1590 | 0.450 |
Why?
|
| Bifidobacterium | 4 | 2023 | 97 | 0.440 |
Why?
|
| Transcription Factors | 16 | 2023 | 12130 | 0.440 |
Why?
|
| Jurkat Cells | 11 | 2011 | 740 | 0.440 |
Why?
|
| Phosphorylation | 17 | 2024 | 8321 | 0.440 |
Why?
|
| Vacuolar Proton-Translocating ATPases | 1 | 2015 | 195 | 0.440 |
Why?
|
| Protein Processing, Post-Translational | 6 | 2020 | 1974 | 0.430 |
Why?
|
| Genetic Markers | 6 | 2018 | 2601 | 0.430 |
Why?
|
| Fibroblasts | 8 | 2024 | 4142 | 0.430 |
Why?
|
| Indoles | 2 | 2021 | 1833 | 0.430 |
Why?
|
| Longitudinal Studies | 15 | 2024 | 14607 | 0.430 |
Why?
|
| Toll-Like Receptor 2 | 6 | 2023 | 347 | 0.430 |
Why?
|
| Caco-2 Cells | 6 | 2021 | 364 | 0.430 |
Why?
|
| Autoantibodies | 2 | 2022 | 2118 | 0.430 |
Why?
|
| Myeloid Cells | 2 | 2017 | 823 | 0.430 |
Why?
|
| Adult | 88 | 2024 | 221200 | 0.430 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 16 | 2018 | 2872 | 0.420 |
Why?
|
| Receptors, Interleukin | 4 | 2022 | 243 | 0.420 |
Why?
|
| Expressed Sequence Tags | 1 | 2013 | 250 | 0.420 |
Why?
|
| Ubiquitin | 3 | 2012 | 839 | 0.420 |
Why?
|
| Lipid Metabolism | 4 | 2023 | 1902 | 0.410 |
Why?
|
| Strongyloides stercoralis | 1 | 2012 | 23 | 0.410 |
Why?
|
| Influenza, Human | 2 | 2022 | 1521 | 0.410 |
Why?
|
| Strongyloidiasis | 1 | 2012 | 27 | 0.410 |
Why?
|
| Lipopolysaccharides | 7 | 2018 | 2206 | 0.410 |
Why?
|
| Genetics, Medical | 1 | 2015 | 334 | 0.410 |
Why?
|
| Alleles | 14 | 2020 | 6864 | 0.410 |
Why?
|
| Proteomics | 6 | 2022 | 3848 | 0.410 |
Why?
|
| Promoter Regions, Genetic | 10 | 2019 | 5790 | 0.410 |
Why?
|
| Leukocytes, Mononuclear | 9 | 2020 | 1844 | 0.400 |
Why?
|
| Antigens | 4 | 2021 | 1443 | 0.400 |
Why?
|
| HTLV-I Infections | 1 | 2012 | 103 | 0.400 |
Why?
|
| Actinobacteria | 2 | 2023 | 59 | 0.390 |
Why?
|
| Systems Biology | 3 | 2018 | 481 | 0.390 |
Why?
|
| Cell Membrane | 7 | 2022 | 3687 | 0.390 |
Why?
|
| Milk, Human | 4 | 2022 | 486 | 0.390 |
Why?
|
| Borrelia burgdorferi | 3 | 2022 | 183 | 0.390 |
Why?
|
| HLA Antigens | 3 | 2023 | 1328 | 0.390 |
Why?
|
| Receptors, Pattern Recognition | 2 | 2013 | 83 | 0.380 |
Why?
|
| Rural Population | 2 | 2021 | 2285 | 0.380 |
Why?
|
| Reactive Oxygen Species | 11 | 2019 | 2140 | 0.380 |
Why?
|
| HT29 Cells | 2 | 2021 | 193 | 0.380 |
Why?
|
| Interspersed Repetitive Sequences | 2 | 2022 | 53 | 0.380 |
Why?
|
| Immunoglobulin A | 4 | 2023 | 978 | 0.380 |
Why?
|
| Antibodies, Neutralizing | 1 | 2021 | 1943 | 0.380 |
Why?
|
| Allergens | 5 | 2023 | 1432 | 0.370 |
Why?
|
| Inflammation Mediators | 9 | 2022 | 1886 | 0.370 |
Why?
|
| Proteolipids | 1 | 2011 | 113 | 0.370 |
Why?
|
| Young Adult | 45 | 2024 | 59254 | 0.370 |
Why?
|
| Candidemia | 4 | 2016 | 39 | 0.370 |
Why?
|
| Listeria monocytogenes | 5 | 2019 | 249 | 0.370 |
Why?
|
| Genetic Association Studies | 6 | 2021 | 2735 | 0.370 |
Why?
|
| Cell Polarity | 7 | 2013 | 636 | 0.370 |
Why?
|
| Leukocyte L1 Antigen Complex | 4 | 2018 | 93 | 0.370 |
Why?
|
| Vaccination | 9 | 2022 | 3384 | 0.370 |
Why?
|
| Immunity, Humoral | 3 | 2021 | 606 | 0.360 |
Why?
|
| Vaccines | 2 | 2017 | 844 | 0.360 |
Why?
|
| Nerve Tissue Proteins | 7 | 2017 | 4415 | 0.360 |
Why?
|
| Pancreatic Neoplasms | 5 | 2024 | 5368 | 0.360 |
Why?
|
| Epigenesis, Genetic | 10 | 2024 | 3801 | 0.360 |
Why?
|
| Proteobacteria | 3 | 2020 | 46 | 0.360 |
Why?
|
| Clostridium Infections | 2 | 2018 | 558 | 0.360 |
Why?
|
| Models, Biological | 14 | 2021 | 9469 | 0.360 |
Why?
|
| Cholangitis, Sclerosing | 2 | 2024 | 177 | 0.360 |
Why?
|
| Gaucher Disease | 5 | 2008 | 110 | 0.360 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 5 | 2012 | 489 | 0.360 |
Why?
|
| Myelin Proteins | 1 | 2011 | 209 | 0.350 |
Why?
|
| Cytoskeleton | 6 | 2011 | 1170 | 0.350 |
Why?
|
| Nitric Oxide | 3 | 2018 | 2135 | 0.350 |
Why?
|
| Actins | 7 | 2016 | 2050 | 0.350 |
Why?
|
| Jejunum | 1 | 2012 | 472 | 0.350 |
Why?
|
| Nematospiroides dubius | 3 | 2017 | 37 | 0.350 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 7 | 2018 | 619 | 0.350 |
Why?
|
| NFATC Transcription Factors | 2 | 2010 | 389 | 0.350 |
Why?
|
| Fungi | 4 | 2019 | 338 | 0.350 |
Why?
|
| Mitochondria | 9 | 2021 | 3624 | 0.350 |
Why?
|
| Acetylmuramyl-Alanyl-Isoglutamine | 3 | 2017 | 20 | 0.350 |
Why?
|
| Mice, Transgenic | 22 | 2021 | 9542 | 0.340 |
Why?
|
| Neutrophils | 7 | 2021 | 3767 | 0.340 |
Why?
|
| Adolescent | 46 | 2024 | 88323 | 0.340 |
Why?
|
| Neutrophil Infiltration | 1 | 2012 | 390 | 0.340 |
Why?
|
| Infant | 16 | 2022 | 36193 | 0.340 |
Why?
|
| Lymphocyte Activation | 11 | 2018 | 5485 | 0.340 |
Why?
|
| Mesalamine | 3 | 2019 | 135 | 0.340 |
Why?
|
| Disease Progression | 7 | 2024 | 13510 | 0.340 |
Why?
|
| Phylogeny | 11 | 2024 | 2811 | 0.340 |
Why?
|
| Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2021 | 114 | 0.340 |
Why?
|
| Case-Control Studies | 24 | 2022 | 22176 | 0.330 |
Why?
|
| High-Throughput Screening Assays | 4 | 2017 | 934 | 0.330 |
Why?
|
| Viruses | 3 | 2023 | 375 | 0.330 |
Why?
|
| Child, Preschool | 19 | 2022 | 42231 | 0.330 |
Why?
|
| Escherichia coli Proteins | 2 | 2019 | 1067 | 0.330 |
Why?
|
| Human Genome Project | 4 | 2016 | 200 | 0.330 |
Why?
|
| Remission Induction | 7 | 2020 | 2397 | 0.330 |
Why?
|
| Gene Regulatory Networks | 6 | 2019 | 1745 | 0.330 |
Why?
|
| Oncogene Proteins | 2 | 2010 | 719 | 0.320 |
Why?
|
| Butyrates | 3 | 2021 | 169 | 0.320 |
Why?
|
| Protein Structure, Tertiary | 7 | 2021 | 3792 | 0.320 |
Why?
|
| Evolution, Molecular | 4 | 2019 | 1886 | 0.320 |
Why?
|
| Cardiovascular Diseases | 4 | 2024 | 15502 | 0.310 |
Why?
|
| Irritable Bowel Syndrome | 2 | 2018 | 455 | 0.310 |
Why?
|
| Lysophospholipids | 3 | 2015 | 338 | 0.310 |
Why?
|
| Chemokine CCL20 | 1 | 2008 | 64 | 0.310 |
Why?
|
| Health Surveys | 1 | 2018 | 4061 | 0.310 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2009 | 193 | 0.310 |
Why?
|
| Bacterial Adhesion | 3 | 2019 | 306 | 0.310 |
Why?
|
| Cluster Analysis | 7 | 2018 | 2707 | 0.310 |
Why?
|
| GTPase-Activating Proteins | 4 | 2014 | 471 | 0.300 |
Why?
|
| Anti-Inflammatory Agents | 7 | 2023 | 1809 | 0.300 |
Why?
|
| Membrane Glycoproteins | 3 | 2015 | 3701 | 0.300 |
Why?
|
| Estonia | 2 | 2018 | 56 | 0.300 |
Why?
|
| Stem Cells | 2 | 2018 | 3524 | 0.300 |
Why?
|
| Bacterial Infections | 4 | 2013 | 1391 | 0.300 |
Why?
|
| Diverticulum | 2 | 2020 | 137 | 0.300 |
Why?
|
| Lipids | 6 | 2023 | 3341 | 0.290 |
Why?
|
| Bacteroides fragilis | 3 | 2019 | 252 | 0.290 |
Why?
|
| Immunomodulation | 3 | 2021 | 549 | 0.290 |
Why?
|
| Mice, Inbred BALB C | 10 | 2021 | 6214 | 0.290 |
Why?
|
| Macrolides | 2 | 2021 | 205 | 0.290 |
Why?
|
| Risk | 6 | 2020 | 9610 | 0.290 |
Why?
|
| Norovirus | 3 | 2012 | 37 | 0.290 |
Why?
|
| Disease Susceptibility | 5 | 2021 | 1787 | 0.290 |
Why?
|
| Child | 31 | 2024 | 80157 | 0.290 |
Why?
|
| Hearing Loss, Noise-Induced | 1 | 2009 | 144 | 0.280 |
Why?
|
| Antigens, Bacterial | 3 | 2023 | 1154 | 0.280 |
Why?
|
| Ovalbumin | 3 | 2015 | 677 | 0.280 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2021 | 1802 | 0.280 |
Why?
|
| Mononuclear Phagocyte System | 2 | 2017 | 53 | 0.280 |
Why?
|
| Middle Aged | 60 | 2024 | 220917 | 0.280 |
Why?
|
| Cytoskeletal Proteins | 3 | 2009 | 1342 | 0.280 |
Why?
|
| Dextran Sulfate | 6 | 2017 | 256 | 0.280 |
Why?
|
| Gene Frequency | 2 | 2020 | 3606 | 0.280 |
Why?
|
| Cardiolipins | 2 | 2023 | 81 | 0.280 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinase 2 | 4 | 2017 | 32 | 0.280 |
Why?
|
| RNA Interference | 9 | 2014 | 2832 | 0.280 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2019 | 2155 | 0.280 |
Why?
|
| Russia | 2 | 2018 | 384 | 0.270 |
Why?
|
| Membrane Lipids | 2 | 2006 | 252 | 0.270 |
Why?
|
| Structure-Activity Relationship | 5 | 2023 | 3076 | 0.270 |
Why?
|
| Membrane Microdomains | 2 | 2019 | 206 | 0.270 |
Why?
|
| Gene Expression | 10 | 2021 | 7581 | 0.270 |
Why?
|
| Asthma | 8 | 2023 | 6234 | 0.270 |
Why?
|
| Protein Transport | 8 | 2016 | 1967 | 0.270 |
Why?
|
| Fibrosis | 4 | 2022 | 2049 | 0.270 |
Why?
|
| Candidiasis | 4 | 2019 | 365 | 0.270 |
Why?
|
| Protein Isoforms | 5 | 2023 | 1699 | 0.270 |
Why?
|
| Vesicular Transport Proteins | 6 | 2020 | 376 | 0.260 |
Why?
|
| Flow Cytometry | 11 | 2016 | 5870 | 0.260 |
Why?
|
| Cell Line, Tumor | 23 | 2021 | 16990 | 0.260 |
Why?
|
| Finland | 2 | 2018 | 607 | 0.260 |
Why?
|
| Gene Knockout Techniques | 3 | 2020 | 802 | 0.260 |
Why?
|
| Tryptophan | 3 | 2018 | 482 | 0.260 |
Why?
|
| Apoptosis | 10 | 2021 | 9491 | 0.260 |
Why?
|
| Glutens | 2 | 2019 | 240 | 0.260 |
Why?
|
| Goblet Cells | 4 | 2017 | 298 | 0.260 |
Why?
|
| Mycobacterium bovis | 2 | 2018 | 147 | 0.260 |
Why?
|
| Respiratory Hypersensitivity | 2 | 2011 | 273 | 0.260 |
Why?
|
| Risk Factors | 29 | 2024 | 74212 | 0.250 |
Why?
|
| Prospective Studies | 24 | 2024 | 54423 | 0.250 |
Why?
|
| Saccharomyces cerevisiae | 3 | 2016 | 2688 | 0.250 |
Why?
|
| DNA, Complementary | 5 | 2017 | 1991 | 0.250 |
Why?
|
| Autoimmune Diseases | 4 | 2024 | 2244 | 0.250 |
Why?
|
| Tumor Suppressor Proteins | 6 | 2018 | 2805 | 0.250 |
Why?
|
| Monomeric GTP-Binding Proteins | 2 | 2006 | 200 | 0.250 |
Why?
|
| Membrane Transport Proteins | 1 | 2011 | 1035 | 0.250 |
Why?
|
| Bacterial Proteins | 4 | 2022 | 3847 | 0.250 |
Why?
|
| Spectrum Analysis, Raman | 2 | 2024 | 237 | 0.250 |
Why?
|
| Immunoprecipitation | 6 | 2018 | 878 | 0.250 |
Why?
|
| Lithocholic Acid | 2 | 2022 | 24 | 0.250 |
Why?
|
| Species Specificity | 5 | 2021 | 2414 | 0.250 |
Why?
|
| Enzyme Inhibitors | 2 | 2015 | 3713 | 0.240 |
Why?
|
| Intestine, Small | 6 | 2018 | 1206 | 0.240 |
Why?
|
| Receptors, Aryl Hydrocarbon | 2 | 2018 | 220 | 0.240 |
Why?
|
| Stress, Physiological | 2 | 2010 | 1403 | 0.240 |
Why?
|
| Strongylida Infections | 2 | 2017 | 48 | 0.240 |
Why?
|
| Mouth | 3 | 2018 | 381 | 0.240 |
Why?
|
| Chordoma | 4 | 2012 | 347 | 0.240 |
Why?
|
| Breast Feeding | 4 | 2022 | 1360 | 0.240 |
Why?
|
| Polysaccharides | 2 | 2022 | 1014 | 0.240 |
Why?
|
| Protein Kinase Inhibitors | 7 | 2018 | 5672 | 0.240 |
Why?
|
| Blood | 5 | 2021 | 596 | 0.240 |
Why?
|
| West Nile virus | 4 | 2014 | 77 | 0.240 |
Why?
|
| Virus Replication | 7 | 2014 | 2435 | 0.240 |
Why?
|
| Adrenal Cortex Hormones | 4 | 2019 | 1881 | 0.240 |
Why?
|
| Smoking | 4 | 2024 | 9053 | 0.240 |
Why?
|
| Myosin Type II | 1 | 2024 | 70 | 0.230 |
Why?
|
| Adaptation, Biological | 2 | 2019 | 147 | 0.230 |
Why?
|
| Islets of Langerhans | 2 | 2022 | 1341 | 0.230 |
Why?
|
| RNA, Messenger | 17 | 2020 | 12794 | 0.230 |
Why?
|
| Staphylococcus aureus | 6 | 2016 | 1457 | 0.230 |
Why?
|
| Receptors, Cell Surface | 3 | 2011 | 2822 | 0.230 |
Why?
|
| src-Family Kinases | 4 | 2016 | 535 | 0.230 |
Why?
|
| Cyst Fluid | 1 | 2024 | 83 | 0.220 |
Why?
|
| Amino Acid Sequence | 9 | 2023 | 13446 | 0.220 |
Why?
|
| Immunophenotyping | 4 | 2021 | 1869 | 0.220 |
Why?
|
| Up-Regulation | 8 | 2019 | 4125 | 0.220 |
Why?
|
| Pouchitis | 2 | 2022 | 64 | 0.220 |
Why?
|
| Lichen Planus, Oral | 1 | 2024 | 57 | 0.220 |
Why?
|
| RNA | 6 | 2024 | 2725 | 0.220 |
Why?
|
| Biological Assay | 3 | 2021 | 626 | 0.220 |
Why?
|
| Extracellular Matrix | 2 | 2022 | 1726 | 0.220 |
Why?
|
| TOR Serine-Threonine Kinases | 6 | 2016 | 2057 | 0.220 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 13 | 2016 | 4576 | 0.220 |
Why?
|
| Tandem Mass Spectrometry | 3 | 2023 | 1188 | 0.220 |
Why?
|
| Candidiasis, Chronic Mucocutaneous | 2 | 2013 | 19 | 0.220 |
Why?
|
| Complement Factor B | 1 | 2023 | 57 | 0.220 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 5 | 2019 | 2273 | 0.220 |
Why?
|
| Hypersensitivity | 3 | 2023 | 1171 | 0.220 |
Why?
|
| Multivariate Analysis | 9 | 2018 | 12059 | 0.220 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 2023 | 2496 | 0.220 |
Why?
|
| Lymphocyte Count | 4 | 2021 | 778 | 0.220 |
Why?
|
| Vitamin D | 2 | 2023 | 3303 | 0.210 |
Why?
|
| Gastrointestinal Diseases | 4 | 2023 | 1200 | 0.210 |
Why?
|
| Enterobacteriaceae | 1 | 2024 | 161 | 0.210 |
Why?
|
| Biodiversity | 4 | 2018 | 347 | 0.210 |
Why?
|
| Mammals | 3 | 2023 | 1132 | 0.210 |
Why?
|
| Eukaryotic Cells | 2 | 2017 | 195 | 0.210 |
Why?
|
| Nitrates | 2 | 2022 | 263 | 0.210 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 2 | 2023 | 502 | 0.210 |
Why?
|
| Allosteric Regulation | 1 | 2024 | 426 | 0.210 |
Why?
|
| Models, Animal | 1 | 2009 | 2112 | 0.210 |
Why?
|
| Diabetes Mellitus, Type 2 | 4 | 2021 | 12149 | 0.210 |
Why?
|
| Streptococcus pyogenes | 2 | 2023 | 292 | 0.210 |
Why?
|
| Klebsiella | 2 | 2024 | 49 | 0.210 |
Why?
|
| Esters | 1 | 2023 | 211 | 0.210 |
Why?
|
| Intestine, Large | 1 | 2022 | 68 | 0.210 |
Why?
|
| Models, Genetic | 7 | 2019 | 3442 | 0.210 |
Why?
|
| Nuclear Proteins | 2 | 2010 | 5799 | 0.210 |
Why?
|
| Isoenzymes | 2 | 2006 | 1687 | 0.210 |
Why?
|
| Diet | 7 | 2021 | 8075 | 0.210 |
Why?
|
| Isoquinolines | 2 | 2021 | 352 | 0.210 |
Why?
|
| Weaning | 1 | 2022 | 103 | 0.210 |
Why?
|
| Cochlea | 1 | 2009 | 845 | 0.210 |
Why?
|
| Proctocolitis | 1 | 2022 | 28 | 0.200 |
Why?
|
| Intra-Abdominal Fat | 2 | 2018 | 613 | 0.200 |
Why?
|
| Galactolipids | 1 | 2022 | 4 | 0.200 |
Why?
|
| Cell Communication | 3 | 2013 | 1657 | 0.200 |
Why?
|
| STAT1 Transcription Factor | 4 | 2013 | 341 | 0.200 |
Why?
|
| Genes, Tumor Suppressor | 3 | 2014 | 1062 | 0.200 |
Why?
|
| Endoplasmic Reticulum | 5 | 2018 | 1134 | 0.200 |
Why?
|
| Cell Proliferation | 17 | 2019 | 10451 | 0.200 |
Why?
|
| Aged | 34 | 2024 | 169308 | 0.200 |
Why?
|
| NF-E2-Related Factor 2 | 2 | 2018 | 372 | 0.200 |
Why?
|
| Phosphatidylethanolamines | 1 | 2022 | 129 | 0.200 |
Why?
|
| Osteogenesis | 2 | 2021 | 1273 | 0.200 |
Why?
|
| Epitopes, T-Lymphocyte | 3 | 2023 | 828 | 0.200 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2024 | 1728 | 0.200 |
Why?
|
| Haplotypes | 5 | 2020 | 2713 | 0.200 |
Why?
|
| Toll-Like Receptors | 4 | 2016 | 589 | 0.200 |
Why?
|
| Protein Kinase C | 1 | 2006 | 1202 | 0.200 |
Why?
|
| Cell Cycle Proteins | 3 | 2016 | 3449 | 0.200 |
Why?
|
| Protein Kinases | 4 | 2021 | 1608 | 0.190 |
Why?
|
| Interleukin-13 | 1 | 2024 | 392 | 0.190 |
Why?
|
| Blotting, Western | 10 | 2016 | 5036 | 0.190 |
Why?
|
| Trypsin | 1 | 2022 | 495 | 0.190 |
Why?
|
| Tunicamycin | 1 | 2021 | 108 | 0.190 |
Why?
|
| Liver Diseases | 1 | 2010 | 1297 | 0.190 |
Why?
|
| Wound Healing | 5 | 2022 | 2805 | 0.190 |
Why?
|
| Germinal Center | 1 | 2024 | 380 | 0.190 |
Why?
|
| Interleukin-17 | 7 | 2022 | 912 | 0.190 |
Why?
|
| Glycosylation | 3 | 2022 | 1097 | 0.190 |
Why?
|
| Alternaria | 2 | 2018 | 42 | 0.190 |
Why?
|
| CD8-Positive T-Lymphocytes | 7 | 2024 | 4580 | 0.190 |
Why?
|
| Defense Mechanisms | 1 | 2021 | 180 | 0.190 |
Why?
|
| High-Throughput Nucleotide Sequencing | 7 | 2019 | 3639 | 0.190 |
Why?
|
| Interferon Regulatory Factor-1 | 3 | 2021 | 68 | 0.190 |
Why?
|
| Mice, Mutant Strains | 4 | 2018 | 1749 | 0.190 |
Why?
|
| Lectins | 1 | 2023 | 491 | 0.190 |
Why?
|
| Principal Component Analysis | 4 | 2019 | 945 | 0.190 |
Why?
|
| Glycolysis | 5 | 2016 | 835 | 0.190 |
Why?
|
| Sorting Nexins | 1 | 2020 | 27 | 0.190 |
Why?
|
| Plasmalogens | 1 | 2020 | 30 | 0.190 |
Why?
|
| Clostridium perfringens | 1 | 2020 | 29 | 0.190 |
Why?
|
| Hepacivirus | 4 | 2011 | 1336 | 0.190 |
Why?
|
| Amides | 1 | 2023 | 449 | 0.180 |
Why?
|
| Antigen-Antibody Reactions | 1 | 2021 | 340 | 0.180 |
Why?
|
| Nissl Bodies | 1 | 2020 | 16 | 0.180 |
Why?
|
| Urbanization | 1 | 2021 | 100 | 0.180 |
Why?
|
| GATA3 Transcription Factor | 1 | 2021 | 154 | 0.180 |
Why?
|
| Optical Tweezers | 2 | 2011 | 85 | 0.180 |
Why?
|
| Listeriosis | 2 | 2019 | 149 | 0.180 |
Why?
|
| Inflammasomes | 4 | 2016 | 526 | 0.180 |
Why?
|
| Age of Onset | 5 | 2021 | 3306 | 0.180 |
Why?
|
| Histidine | 1 | 2021 | 308 | 0.180 |
Why?
|
| Down-Regulation | 7 | 2018 | 2919 | 0.180 |
Why?
|
| Aldehydes | 1 | 2021 | 170 | 0.180 |
Why?
|
| Biosynthetic Pathways | 1 | 2021 | 136 | 0.180 |
Why?
|
| Amino Acids | 3 | 2022 | 1718 | 0.180 |
Why?
|
| Microbial Consortia | 1 | 2020 | 33 | 0.180 |
Why?
|
| Obesity | 7 | 2020 | 12947 | 0.180 |
Why?
|
| Cytosol | 3 | 2021 | 888 | 0.180 |
Why?
|
| Tanzania | 2 | 2024 | 1387 | 0.180 |
Why?
|
| Chromosomes, Human, Pair 7 | 2 | 2018 | 310 | 0.180 |
Why?
|
| Oligosaccharides | 1 | 2022 | 406 | 0.180 |
Why?
|
| Gene Transfer, Horizontal | 1 | 2021 | 145 | 0.180 |
Why?
|
| Bangladesh | 1 | 2022 | 736 | 0.180 |
Why?
|
| Antibodies, Viral | 2 | 2022 | 3156 | 0.180 |
Why?
|
| ADAM Proteins | 1 | 2022 | 238 | 0.180 |
Why?
|
| ras Proteins | 3 | 2013 | 1054 | 0.170 |
Why?
|
| eIF-2 Kinase | 1 | 2021 | 145 | 0.170 |
Why?
|
| Gene Pool | 1 | 2019 | 36 | 0.170 |
Why?
|
| Bacterial Capsules | 1 | 2021 | 244 | 0.170 |
Why?
|
| Adenosine Triphosphate | 3 | 2022 | 1989 | 0.170 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2024 | 517 | 0.170 |
Why?
|
| Orthomyxoviridae Infections | 2 | 2013 | 254 | 0.170 |
Why?
|
| Molecular Typing | 1 | 2020 | 116 | 0.170 |
Why?
|
| Mutation | 17 | 2021 | 30054 | 0.170 |
Why?
|
| Protein Structure, Quaternary | 1 | 2021 | 429 | 0.170 |
Why?
|
| Interleukins | 3 | 2016 | 782 | 0.170 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2021 | 419 | 0.170 |
Why?
|
| Phenylalanine | 1 | 2021 | 366 | 0.170 |
Why?
|
| Operon | 1 | 2020 | 372 | 0.170 |
Why?
|
| Lactobacillus | 2 | 2023 | 212 | 0.170 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2021 | 181 | 0.170 |
Why?
|
| Fatty Acids, Volatile | 2 | 2018 | 103 | 0.170 |
Why?
|
| I-kappa B Proteins | 1 | 2000 | 211 | 0.170 |
Why?
|
| Duodenum | 2 | 2020 | 490 | 0.170 |
Why?
|
| Myosin Heavy Chains | 1 | 2021 | 405 | 0.170 |
Why?
|
| Receptors, Calcitonin Gene-Related Peptide | 1 | 2019 | 31 | 0.170 |
Why?
|
| Bone Marrow Cells | 5 | 2022 | 2417 | 0.170 |
Why?
|
| Time | 1 | 2021 | 546 | 0.170 |
Why?
|
| Mucins | 3 | 2017 | 568 | 0.170 |
Why?
|
| Dipeptides | 1 | 2021 | 391 | 0.170 |
Why?
|
| Carnitine | 1 | 2021 | 252 | 0.170 |
Why?
|
| Base Sequence | 6 | 2019 | 12441 | 0.170 |
Why?
|
| Nuclear Receptor Subfamily 1, Group D, Member 1 | 1 | 2019 | 33 | 0.160 |
Why?
|
| Multifactorial Inheritance | 2 | 2023 | 1387 | 0.160 |
Why?
|
| Feedback, Physiological | 2 | 2019 | 476 | 0.160 |
Why?
|
| Antigen-Antibody Complex | 1 | 2021 | 510 | 0.160 |
Why?
|
| Kangai-1 Protein | 1 | 2019 | 22 | 0.160 |
Why?
|
| Triazoles | 1 | 2005 | 903 | 0.160 |
Why?
|
| Genetic Testing | 4 | 2018 | 3537 | 0.160 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2012 | 1745 | 0.160 |
Why?
|
| Insulin Receptor Substrate Proteins | 2 | 2019 | 557 | 0.160 |
Why?
|
| Uropathogenic Escherichia coli | 1 | 2018 | 6 | 0.160 |
Why?
|
| Cytokine Receptor Common beta Subunit | 1 | 2019 | 22 | 0.160 |
Why?
|
| Peptides | 8 | 2023 | 4358 | 0.160 |
Why?
|
| Protein Folding | 1 | 2023 | 870 | 0.160 |
Why?
|
| Registries | 9 | 2018 | 8224 | 0.160 |
Why?
|
| alpha-Defensins | 1 | 2018 | 30 | 0.160 |
Why?
|
| Lipid Mobilization | 1 | 2018 | 16 | 0.160 |
Why?
|
| DEAD-box RNA Helicases | 2 | 2015 | 384 | 0.160 |
Why?
|
| Interleukin-5 | 1 | 2019 | 269 | 0.160 |
Why?
|
| Genes, Mitochondrial | 1 | 2019 | 59 | 0.160 |
Why?
|
| Mouth Neoplasms | 1 | 2024 | 596 | 0.160 |
Why?
|
| Antifungal Agents | 1 | 2024 | 753 | 0.160 |
Why?
|
| Carbon | 1 | 2022 | 666 | 0.160 |
Why?
|
| Genetic Loci | 4 | 2019 | 2632 | 0.160 |
Why?
|
| Cell Survival | 6 | 2016 | 5791 | 0.160 |
Why?
|
| Transcriptional Activation | 2 | 2020 | 1756 | 0.160 |
Why?
|
| Specific Pathogen-Free Organisms | 2 | 2015 | 221 | 0.160 |
Why?
|
| Mucin-2 | 2 | 2017 | 50 | 0.160 |
Why?
|
| Epitopes | 2 | 2017 | 2503 | 0.160 |
Why?
|
| Apolipoprotein A-I | 3 | 2017 | 299 | 0.160 |
Why?
|
| Peyer's Patches | 1 | 2018 | 120 | 0.160 |
Why?
|
| Pyrophosphatases | 1 | 2019 | 142 | 0.150 |
Why?
|
| Meconium | 1 | 2018 | 47 | 0.150 |
Why?
|
| Biological Factors | 1 | 2019 | 157 | 0.150 |
Why?
|
| Interferon Regulatory Factor-3 | 3 | 2014 | 141 | 0.150 |
Why?
|
| Phagocytosis | 4 | 2023 | 1528 | 0.150 |
Why?
|
| Ruminococcus | 1 | 2017 | 11 | 0.150 |
Why?
|
| Yellow fever virus | 1 | 2018 | 23 | 0.150 |
Why?
|
| Urease | 1 | 2017 | 39 | 0.150 |
Why?
|
| Colonic Polyps | 1 | 2023 | 554 | 0.150 |
Why?
|
| Urothelium | 2 | 2018 | 269 | 0.150 |
Why?
|
| Cell Membrane Permeability | 2 | 2017 | 575 | 0.150 |
Why?
|
| Molecular Structure | 2 | 2017 | 1880 | 0.150 |
Why?
|
| Mast Cells | 2 | 2016 | 1392 | 0.150 |
Why?
|
| Fatty Acids | 2 | 2023 | 1808 | 0.150 |
Why?
|
| Spermatogenesis | 1 | 2019 | 259 | 0.150 |
Why?
|
| ARNTL Transcription Factors | 1 | 2018 | 96 | 0.150 |
Why?
|
| Human Body | 1 | 2017 | 38 | 0.150 |
Why?
|
| Glucosylceramidase | 3 | 2008 | 127 | 0.150 |
Why?
|
| Familial Mediterranean Fever | 1 | 2018 | 65 | 0.150 |
Why?
|
| Interleukin-23 | 2 | 2022 | 201 | 0.150 |
Why?
|
| Toll-Like Receptor 1 | 2 | 2022 | 48 | 0.150 |
Why?
|
| Arginine | 1 | 2021 | 934 | 0.150 |
Why?
|
| Forkhead Transcription Factors | 3 | 2021 | 1616 | 0.150 |
Why?
|
| Escherichia coli | 5 | 2020 | 4217 | 0.150 |
Why?
|
| Smad3 Protein | 2 | 2017 | 166 | 0.150 |
Why?
|
| Netherlands | 5 | 2024 | 2221 | 0.140 |
Why?
|
| Yellow Fever | 1 | 2018 | 54 | 0.140 |
Why?
|
| ADP-Ribosylation Factors | 1 | 2018 | 133 | 0.140 |
Why?
|
| Receptors, IgE | 2 | 2016 | 375 | 0.140 |
Why?
|
| Bone Resorption | 1 | 2021 | 723 | 0.140 |
Why?
|
| Reoviridae Infections | 1 | 2017 | 59 | 0.140 |
Why?
|
| Enteric Nervous System | 1 | 2020 | 212 | 0.140 |
Why?
|
| Pancreas | 1 | 2024 | 1691 | 0.140 |
Why?
|
| Muramidase | 1 | 2017 | 169 | 0.140 |
Why?
|
| Listeria | 1 | 2016 | 25 | 0.140 |
Why?
|
| Meiosis | 1 | 2019 | 328 | 0.140 |
Why?
|
| Cryoelectron Microscopy | 1 | 2021 | 650 | 0.140 |
Why?
|
| Genes, Bacterial | 1 | 2020 | 1073 | 0.140 |
Why?
|
| Drug Resistance, Microbial | 2 | 2018 | 825 | 0.140 |
Why?
|
| Virus Diseases | 2 | 2018 | 718 | 0.140 |
Why?
|
| Dietary Fiber | 1 | 2021 | 759 | 0.140 |
Why?
|
| Genetic Engineering | 3 | 2023 | 933 | 0.140 |
Why?
|
| Microscopy, Confocal | 6 | 2016 | 1971 | 0.140 |
Why?
|
| DNA Damage | 2 | 2017 | 2449 | 0.140 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 1 | 2016 | 64 | 0.140 |
Why?
|
| Molecular Sequence Annotation | 2 | 2023 | 522 | 0.130 |
Why?
|
| Granuloma | 2 | 2016 | 328 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 1 | 2016 | 120 | 0.130 |
Why?
|
| Microscopy, Fluorescence | 5 | 2014 | 2645 | 0.130 |
Why?
|
| DNA Methylation | 2 | 2024 | 4399 | 0.130 |
Why?
|
| Jews | 1 | 2018 | 356 | 0.130 |
Why?
|
| Antirheumatic Agents | 2 | 2016 | 1373 | 0.130 |
Why?
|
| Glycoproteins | 2 | 2022 | 2203 | 0.130 |
Why?
|
| Macrophage Activation | 2 | 2016 | 553 | 0.130 |
Why?
|
| Atlases as Topic | 1 | 2017 | 248 | 0.130 |
Why?
|
| Polysaccharides, Bacterial | 1 | 2019 | 578 | 0.130 |
Why?
|
| COS Cells | 5 | 2011 | 1130 | 0.130 |
Why?
|
| Crystallography, X-Ray | 1 | 2021 | 1990 | 0.130 |
Why?
|
| Integrin alphaV | 1 | 2016 | 54 | 0.130 |
Why?
|
| Integrins | 2 | 2019 | 834 | 0.130 |
Why?
|
| Drug Tolerance | 1 | 2018 | 367 | 0.130 |
Why?
|
| Food Microbiology | 1 | 2016 | 74 | 0.130 |
Why?
|
| Parkinson Disease | 1 | 2010 | 2877 | 0.130 |
Why?
|
| Mitogen-Activated Protein Kinases | 6 | 2014 | 1246 | 0.130 |
Why?
|
| Mice, Inbred NOD | 2 | 2021 | 1827 | 0.130 |
Why?
|
| Invertebrates | 1 | 2016 | 55 | 0.130 |
Why?
|
| Fumarates | 1 | 2016 | 131 | 0.130 |
Why?
|
| X-Linked Inhibitor of Apoptosis Protein | 1 | 2016 | 61 | 0.130 |
Why?
|
| Succinic Acid | 1 | 2016 | 86 | 0.130 |
Why?
|
| Receptors, Interleukin-1 | 2 | 2014 | 262 | 0.130 |
Why?
|
| Methyltransferases | 1 | 2019 | 377 | 0.130 |
Why?
|
| Molecular Targeted Therapy | 2 | 2018 | 2811 | 0.130 |
Why?
|
| Reproducibility of Results | 9 | 2023 | 20099 | 0.130 |
Why?
|
| Colonic Neoplasms | 4 | 2013 | 2538 | 0.130 |
Why?
|
| Protein Multimerization | 1 | 2021 | 983 | 0.130 |
Why?
|
| Gene Deletion | 4 | 2016 | 2665 | 0.130 |
Why?
|
| Phosphofructokinase-1 | 1 | 2015 | 51 | 0.130 |
Why?
|
| Succinate Dehydrogenase | 1 | 2016 | 145 | 0.130 |
Why?
|
| Colonic Diseases | 1 | 2017 | 201 | 0.130 |
Why?
|
| Eye Diseases | 2 | 2024 | 653 | 0.130 |
Why?
|
| Protons | 1 | 2021 | 1116 | 0.130 |
Why?
|
| Harmine | 1 | 2015 | 11 | 0.130 |
Why?
|
| Embryo, Mammalian | 2 | 2011 | 1674 | 0.130 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 2 | 2006 | 174 | 0.130 |
Why?
|
| Recombinant Proteins | 5 | 2019 | 6534 | 0.130 |
Why?
|
| Gene Targeting | 3 | 2016 | 838 | 0.130 |
Why?
|
| Logistic Models | 7 | 2024 | 13255 | 0.130 |
Why?
|
| Molecular Sequence Data | 6 | 2015 | 17635 | 0.130 |
Why?
|
| Tuberculosis | 4 | 2019 | 2017 | 0.130 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 8 | 2014 | 3779 | 0.130 |
Why?
|
| Microviridae | 1 | 2015 | 3 | 0.130 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 2 | 2014 | 299 | 0.120 |
Why?
|
| Caudovirales | 1 | 2015 | 3 | 0.120 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2016 | 465 | 0.120 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2019 | 891 | 0.120 |
Why?
|
| Wnt Proteins | 2 | 2010 | 718 | 0.120 |
Why?
|
| Cell Aggregation | 1 | 2015 | 239 | 0.120 |
Why?
|
| Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 2015 | 121 | 0.120 |
Why?
|
| Cornified Envelope Proline-Rich Proteins | 1 | 2014 | 15 | 0.120 |
Why?
|
| Algorithms | 6 | 2019 | 14032 | 0.120 |
Why?
|
| Granulomatous Disease, Chronic | 2 | 2014 | 173 | 0.120 |
Why?
|
| Mitochondrial Diseases | 1 | 2019 | 343 | 0.120 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2017 | 1334 | 0.120 |
Why?
|
| Osteocytes | 1 | 2016 | 192 | 0.120 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2018 | 598 | 0.120 |
Why?
|
| Lymphoma, B-Cell | 2 | 2013 | 940 | 0.120 |
Why?
|
| Lyme Disease | 2 | 2022 | 631 | 0.120 |
Why?
|
| Spermatozoa | 1 | 2019 | 630 | 0.120 |
Why?
|
| Cell Nucleus | 2 | 2020 | 2910 | 0.120 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2013 | 226 | 0.120 |
Why?
|
| Receptors, Immunologic | 2 | 2019 | 1410 | 0.120 |
Why?
|
| Mice, 129 Strain | 1 | 2015 | 371 | 0.120 |
Why?
|
| Caspases | 3 | 2006 | 879 | 0.120 |
Why?
|
| Myeloid Differentiation Factor 88 | 2 | 2011 | 587 | 0.120 |
Why?
|
| Ascorbic Acid | 1 | 2018 | 655 | 0.120 |
Why?
|
| Vegetables | 1 | 2020 | 1195 | 0.120 |
Why?
|
| Tretinoin | 1 | 2017 | 519 | 0.120 |
Why?
|
| Cholera Toxin | 1 | 2017 | 559 | 0.120 |
Why?
|
| Age Factors | 4 | 2018 | 18398 | 0.120 |
Why?
|
| Parathyroid Hormone | 2 | 2023 | 1803 | 0.120 |
Why?
|
| Plants | 1 | 2016 | 327 | 0.120 |
Why?
|
| Food Hypersensitivity | 1 | 2022 | 729 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-jun | 2 | 2021 | 287 | 0.120 |
Why?
|
| Mycobacterium | 2 | 2013 | 251 | 0.120 |
Why?
|
| Toxoplasmosis | 1 | 2015 | 94 | 0.120 |
Why?
|
| Receptors, Interleukin-12 | 1 | 2014 | 26 | 0.120 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 1 | 2014 | 56 | 0.120 |
Why?
|
| Oxidative Stress | 4 | 2018 | 3113 | 0.120 |
Why?
|
| Fertility | 1 | 2019 | 771 | 0.120 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2021 | 1363 | 0.120 |
Why?
|
| Toxoplasma | 1 | 2015 | 157 | 0.120 |
Why?
|
| Genome | 5 | 2023 | 1740 | 0.120 |
Why?
|
| Galectin 3 | 1 | 2016 | 240 | 0.120 |
Why?
|
| Receptor Aggregation | 1 | 1994 | 72 | 0.120 |
Why?
|
| ATP-Binding Cassette Transporters | 2 | 2008 | 563 | 0.110 |
Why?
|
| Glutathione S-Transferase pi | 1 | 2014 | 99 | 0.110 |
Why?
|
| Mucous Membrane | 2 | 2015 | 659 | 0.110 |
Why?
|
| Protein Interaction Mapping | 2 | 2015 | 616 | 0.110 |
Why?
|
| Gammaherpesvirinae | 1 | 2013 | 27 | 0.110 |
Why?
|
| Candida | 1 | 2015 | 172 | 0.110 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2020 | 3612 | 0.110 |
Why?
|
| Adenocarcinoma | 3 | 2019 | 6346 | 0.110 |
Why?
|
| Aging | 6 | 2024 | 8711 | 0.110 |
Why?
|
| HCT116 Cells | 4 | 2017 | 404 | 0.110 |
Why?
|
| Genes, Reporter | 6 | 2009 | 1529 | 0.110 |
Why?
|
| Gossypol | 1 | 2013 | 23 | 0.110 |
Why?
|
| Dermatitis, Atopic | 1 | 2021 | 731 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 10 | 2 | 2021 | 277 | 0.110 |
Why?
|
| Colonic Pouches | 1 | 2015 | 122 | 0.110 |
Why?
|
| Cell Compartmentation | 3 | 1999 | 384 | 0.110 |
Why?
|
| Organic Anion Transporters | 1 | 2014 | 101 | 0.110 |
Why?
|
| Fucosyltransferases | 2 | 2012 | 117 | 0.110 |
Why?
|
| beta-Glucans | 4 | 2014 | 123 | 0.110 |
Why?
|
| Glutamine | 1 | 2016 | 577 | 0.110 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2020 | 1351 | 0.110 |
Why?
|
| Corynebacterium | 1 | 2013 | 48 | 0.110 |
Why?
|
| Cell-Penetrating Peptides | 1 | 2013 | 49 | 0.110 |
Why?
|
| Acinetobacter | 1 | 2013 | 39 | 0.110 |
Why?
|
| Phosphatidylinositol 3-Kinases | 5 | 2021 | 2865 | 0.110 |
Why?
|
| Glucose | 6 | 2018 | 4347 | 0.110 |
Why?
|
| Colectomy | 1 | 2018 | 688 | 0.110 |
Why?
|
| Genomic Imprinting | 2 | 2014 | 329 | 0.110 |
Why?
|
| Transcription Factor CHOP | 1 | 2013 | 68 | 0.110 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2014 | 224 | 0.110 |
Why?
|
| Interleukin-6 | 7 | 2020 | 3208 | 0.110 |
Why?
|
| Intracellular Space | 2 | 2016 | 197 | 0.110 |
Why?
|
| Pyruvate Kinase | 1 | 2015 | 189 | 0.110 |
Why?
|
| Adjuvants, Immunologic | 2 | 2015 | 1036 | 0.110 |
Why?
|
| Proto-Oncogene Proteins | 4 | 2013 | 4514 | 0.110 |
Why?
|
| Chemokines | 2 | 2014 | 959 | 0.100 |
Why?
|
| Secretory Vesicles | 1 | 2013 | 128 | 0.100 |
Why?
|
| Genes, Dominant | 1 | 2015 | 852 | 0.100 |
Why?
|
| Rare Diseases | 1 | 2018 | 622 | 0.100 |
Why?
|
| Heat-Shock Proteins | 2 | 2018 | 795 | 0.100 |
Why?
|
| Energy Metabolism | 2 | 2021 | 2882 | 0.100 |
Why?
|
| Caenorhabditis elegans | 3 | 2013 | 1456 | 0.100 |
Why?
|
| Transcription Factor RelB | 1 | 2012 | 28 | 0.100 |
Why?
|
| Recombinant Fusion Proteins | 5 | 2015 | 3733 | 0.100 |
Why?
|
| Interferon-beta | 1 | 2014 | 345 | 0.100 |
Why?
|
| Microscopy | 2 | 2024 | 903 | 0.100 |
Why?
|
| Protein Stability | 1 | 2014 | 578 | 0.100 |
Why?
|
| Interleukin-7 | 1 | 2013 | 143 | 0.100 |
Why?
|
| Lung | 5 | 2016 | 10002 | 0.100 |
Why?
|
| Adenoma | 1 | 2023 | 2163 | 0.100 |
Why?
|
| Enzyme Activation | 5 | 2013 | 3597 | 0.100 |
Why?
|
| Sialyltransferases | 1 | 2012 | 83 | 0.100 |
Why?
|
| Intestinal Perforation | 1 | 2014 | 249 | 0.100 |
Why?
|
| Caliciviridae Infections | 1 | 2012 | 29 | 0.100 |
Why?
|
| Minisatellite Repeats | 1 | 2013 | 163 | 0.100 |
Why?
|
| Niacinamide | 1 | 2014 | 413 | 0.100 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 2 | 2023 | 152 | 0.100 |
Why?
|
| North America | 2 | 2014 | 1276 | 0.100 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2023 | 3397 | 0.100 |
Why?
|
| Urinary Tract Infections | 1 | 2018 | 802 | 0.100 |
Why?
|
| Cell Culture Techniques | 3 | 2015 | 1668 | 0.100 |
Why?
|
| Herpesviridae Infections | 1 | 2013 | 270 | 0.100 |
Why?
|
| Databases, Nucleic Acid | 1 | 2013 | 205 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-myc | 3 | 2013 | 988 | 0.100 |
Why?
|
| Lysine | 1 | 2016 | 993 | 0.100 |
Why?
|
| Mothers | 1 | 2022 | 2198 | 0.100 |
Why?
|
| Glutathione Transferase | 1 | 2014 | 565 | 0.100 |
Why?
|
| Toll-Like Receptor 5 | 1 | 2012 | 42 | 0.100 |
Why?
|
| Aspergillus fumigatus | 4 | 2016 | 157 | 0.100 |
Why?
|
| Cell Movement | 7 | 2024 | 5205 | 0.100 |
Why?
|
| Human T-lymphotropic virus 1 | 1 | 2012 | 142 | 0.100 |
Why?
|
| Adoptive Transfer | 3 | 2013 | 819 | 0.100 |
Why?
|
| Multigene Family | 3 | 2024 | 1076 | 0.100 |
Why?
|
| Polycystic Kidney, Autosomal Dominant | 1 | 2013 | 166 | 0.100 |
Why?
|
| Peritoneum | 1 | 2013 | 225 | 0.100 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2012 | 8553 | 0.100 |
Why?
|
| Amino Acid Motifs | 3 | 2016 | 931 | 0.100 |
Why?
|
| Heme Oxygenase-1 | 1 | 2014 | 366 | 0.100 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2012 | 163 | 0.100 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2013 | 239 | 0.100 |
Why?
|
| Cesarean Section | 2 | 2020 | 1398 | 0.100 |
Why?
|
| Models, Immunological | 1 | 2014 | 513 | 0.100 |
Why?
|
| Oligopeptides | 1 | 2017 | 1187 | 0.100 |
Why?
|
| Body Mass Index | 4 | 2020 | 12953 | 0.100 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2013 | 225 | 0.100 |
Why?
|
| Secondary Prevention | 1 | 2018 | 1475 | 0.100 |
Why?
|
| Spermine | 1 | 2011 | 70 | 0.100 |
Why?
|
| Macrophages, Peritoneal | 1 | 2012 | 238 | 0.090 |
Why?
|
| Interleukin-12 | 1 | 2014 | 584 | 0.090 |
Why?
|
| Neoplasms | 4 | 2024 | 22172 | 0.090 |
Why?
|
| Lymphoid Tissue | 1 | 2013 | 445 | 0.090 |
Why?
|
| Caspase 8 | 1 | 2011 | 190 | 0.090 |
Why?
|
| Endothelial Cells | 1 | 2024 | 3549 | 0.090 |
Why?
|
| Tularemia | 1 | 2011 | 42 | 0.090 |
Why?
|
| Occult Blood | 1 | 1992 | 198 | 0.090 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2022 | 1642 | 0.090 |
Why?
|
| Sequence Deletion | 3 | 2012 | 1494 | 0.090 |
Why?
|
| Spleen | 2 | 2018 | 2295 | 0.090 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2013 | 289 | 0.090 |
Why?
|
| Longevity | 2 | 2023 | 1065 | 0.090 |
Why?
|
| Two-Hybrid System Techniques | 3 | 2006 | 460 | 0.090 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2013 | 477 | 0.090 |
Why?
|
| Oncogenes | 2 | 2014 | 1222 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 3 | 2008 | 473 | 0.090 |
Why?
|
| Francisella tularensis | 1 | 2011 | 62 | 0.090 |
Why?
|
| Green Fluorescent Proteins | 2 | 2015 | 2065 | 0.090 |
Why?
|
| Aged, 80 and over | 9 | 2024 | 58983 | 0.090 |
Why?
|
| Constriction, Pathologic | 3 | 2021 | 1096 | 0.090 |
Why?
|
| Neoplasm Proteins | 5 | 2017 | 3617 | 0.090 |
Why?
|
| Virus Latency | 1 | 2013 | 363 | 0.090 |
Why?
|
| Proton Pump Inhibitors | 1 | 2015 | 532 | 0.090 |
Why?
|
| Gastroenteritis | 1 | 2012 | 236 | 0.090 |
Why?
|
| Air Pollution, Indoor | 1 | 2018 | 901 | 0.090 |
Why?
|
| Mucositis | 1 | 2011 | 108 | 0.090 |
Why?
|
| Environment | 1 | 2016 | 1123 | 0.090 |
Why?
|
| Infant, Newborn | 4 | 2019 | 26198 | 0.090 |
Why?
|
| Environmental Exposure | 2 | 2016 | 4485 | 0.090 |
Why?
|
| Gastrointestinal Neoplasms | 2 | 2008 | 954 | 0.090 |
Why?
|
| Chromatography, Liquid | 1 | 2014 | 983 | 0.090 |
Why?
|
| Lymph Nodes | 2 | 2016 | 3466 | 0.090 |
Why?
|
| Pedigree | 1 | 2018 | 4542 | 0.090 |
Why?
|
| Gene Silencing | 2 | 2014 | 1509 | 0.090 |
Why?
|
| Flavivirus Infections | 1 | 2009 | 15 | 0.090 |
Why?
|
| Electronic Health Records | 2 | 2019 | 4811 | 0.090 |
Why?
|
| Cell Hypoxia | 2 | 2010 | 657 | 0.090 |
Why?
|
| Biological Products | 1 | 2019 | 914 | 0.090 |
Why?
|
| Treatment Outcome | 9 | 2020 | 64684 | 0.090 |
Why?
|
| Databases, Protein | 2 | 2023 | 387 | 0.090 |
Why?
|
| Leukemia, T-Cell | 1 | 2010 | 101 | 0.090 |
Why?
|
| Life Style | 1 | 2021 | 3917 | 0.090 |
Why?
|
| Morphogenesis | 1 | 2014 | 741 | 0.090 |
Why?
|
| Mitochondrial Size | 1 | 2009 | 8 | 0.090 |
Why?
|
| Angiotensin II | 1 | 2013 | 849 | 0.080 |
Why?
|
| RNA-Binding Proteins | 2 | 2016 | 1898 | 0.080 |
Why?
|
| Luciferases | 3 | 2012 | 714 | 0.080 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2020 | 1469 | 0.080 |
Why?
|
| Gastroenterology | 1 | 2016 | 577 | 0.080 |
Why?
|
| Genes, Neoplasm | 1 | 2011 | 370 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-vav | 2 | 2006 | 91 | 0.080 |
Why?
|
| Fluorescent Antibody Technique | 3 | 2010 | 2468 | 0.080 |
Why?
|
| Receptors, Growth Factor | 1 | 2010 | 326 | 0.080 |
Why?
|
| Muscle Proteins | 3 | 2008 | 1154 | 0.080 |
Why?
|
| Cytoprotection | 1 | 2009 | 200 | 0.080 |
Why?
|
| Chemotactic Factors | 1 | 2009 | 197 | 0.080 |
Why?
|
| Radiography, Abdominal | 1 | 2012 | 534 | 0.080 |
Why?
|
| Schools | 1 | 2018 | 1489 | 0.080 |
Why?
|
| Colorectal Neoplasms | 2 | 2023 | 6938 | 0.080 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2013 | 1115 | 0.080 |
Why?
|
| Antibodies, Monoclonal | 3 | 2021 | 9177 | 0.080 |
Why?
|
| Acetaminophen | 1 | 2013 | 554 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2017 | 10766 | 0.080 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2023 | 2242 | 0.080 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2024 | 1860 | 0.080 |
Why?
|
| Herpesvirus 1, Human | 1 | 2014 | 753 | 0.080 |
Why?
|
| Receptors, Virus | 1 | 2012 | 640 | 0.080 |
Why?
|
| Binding Sites | 3 | 2017 | 6056 | 0.080 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2013 | 682 | 0.080 |
Why?
|
| Sex Factors | 3 | 2024 | 10554 | 0.080 |
Why?
|
| Affect | 1 | 2016 | 1486 | 0.080 |
Why?
|
| Severity of Illness Index | 8 | 2019 | 15843 | 0.080 |
Why?
|
| Neurons | 2 | 2020 | 9463 | 0.080 |
Why?
|
| Odds Ratio | 5 | 2020 | 9646 | 0.080 |
Why?
|
| Muscle, Smooth | 2 | 2016 | 926 | 0.080 |
Why?
|
| NADH, NADPH Oxidoreductases | 2 | 2006 | 94 | 0.080 |
Why?
|
| Substrate Specificity | 2 | 2010 | 1791 | 0.080 |
Why?
|
| Biological Transport | 3 | 2012 | 2091 | 0.080 |
Why?
|
| Killer Cells, Natural | 2 | 2014 | 2201 | 0.080 |
Why?
|
| Health Status Disparities | 1 | 2020 | 1852 | 0.080 |
Why?
|
| Serine C-Palmitoyltransferase | 1 | 2008 | 42 | 0.080 |
Why?
|
| Medical History Taking | 1 | 1992 | 774 | 0.080 |
Why?
|
| Necrosis | 2 | 2011 | 1611 | 0.080 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2009 | 200 | 0.080 |
Why?
|
| West Nile Fever | 1 | 2008 | 75 | 0.080 |
Why?
|
| Histones | 2 | 2016 | 2580 | 0.080 |
Why?
|
| Genetic Heterogeneity | 2 | 2024 | 732 | 0.080 |
Why?
|
| Colonoscopy | 3 | 2023 | 1394 | 0.080 |
Why?
|
| Oxidation-Reduction | 3 | 2020 | 2231 | 0.080 |
Why?
|
| Antibody Formation | 1 | 2013 | 1395 | 0.080 |
Why?
|
| Schizophrenia | 2 | 2022 | 6937 | 0.080 |
Why?
|
| Mucin-1 | 1 | 2013 | 540 | 0.080 |
Why?
|
| Presenilin-2 | 1 | 2008 | 95 | 0.080 |
Why?
|
| Immunoglobulin E | 2 | 2022 | 1502 | 0.080 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2011 | 698 | 0.070 |
Why?
|
| Benzimidazoles | 1 | 2013 | 858 | 0.070 |
Why?
|
| PDZ Domains | 1 | 2007 | 23 | 0.070 |
Why?
|
| Stromal Cells | 3 | 2020 | 1330 | 0.070 |
Why?
|
| rac GTP-Binding Proteins | 2 | 2006 | 162 | 0.070 |
Why?
|
| Pelvis | 1 | 2012 | 733 | 0.070 |
Why?
|
| Wiskott-Aldrich Syndrome Protein, Neuronal | 1 | 2007 | 87 | 0.070 |
Why?
|
| Recurrence | 3 | 2020 | 8466 | 0.070 |
Why?
|
| Bone and Bones | 3 | 2016 | 2568 | 0.070 |
Why?
|
| Psoriasis | 1 | 2016 | 950 | 0.070 |
Why?
|
| Benzamides | 1 | 2013 | 1370 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-met | 2 | 2010 | 571 | 0.070 |
Why?
|
| Socioeconomic Factors | 1 | 2021 | 7827 | 0.070 |
Why?
|
| Time Factors | 8 | 2018 | 39970 | 0.070 |
Why?
|
| Leukocytes | 4 | 2016 | 2026 | 0.070 |
Why?
|
| Liver | 3 | 2021 | 7527 | 0.070 |
Why?
|
| A Kinase Anchor Proteins | 1 | 2007 | 57 | 0.070 |
Why?
|
| Anaphylaxis | 1 | 2014 | 757 | 0.070 |
Why?
|
| Enterocytes | 2 | 2019 | 220 | 0.070 |
Why?
|
| Phosphatidylglycerols | 1 | 2006 | 34 | 0.070 |
Why?
|
| Ionomycin | 1 | 2006 | 110 | 0.070 |
Why?
|
| Child Development | 1 | 2018 | 2306 | 0.070 |
Why?
|
| Diagnosis, Differential | 3 | 2012 | 12973 | 0.070 |
Why?
|
| Pneumonia | 1 | 2018 | 2143 | 0.070 |
Why?
|
| Wiskott-Aldrich Syndrome Protein | 1 | 2007 | 161 | 0.070 |
Why?
|
| Ionophores | 1 | 2006 | 107 | 0.070 |
Why?
|
| Plasmids | 3 | 2006 | 2269 | 0.070 |
Why?
|
| Adiposity | 1 | 2017 | 1879 | 0.070 |
Why?
|
| Carcinoid Tumor | 1 | 2008 | 224 | 0.070 |
Why?
|
| Noise | 1 | 2009 | 290 | 0.070 |
Why?
|
| Gene Dosage | 1 | 2011 | 1218 | 0.070 |
Why?
|
| Tyrosine | 1 | 2011 | 1440 | 0.070 |
Why?
|
| Histone Deacetylases | 3 | 2018 | 720 | 0.070 |
Why?
|
| Chronic Disease | 5 | 2022 | 9319 | 0.070 |
Why?
|
| Acetophenones | 1 | 2006 | 53 | 0.070 |
Why?
|
| ets-Domain Protein Elk-1 | 1 | 2006 | 39 | 0.070 |
Why?
|
| Bacterial Load | 2 | 2017 | 152 | 0.070 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2007 | 234 | 0.070 |
Why?
|
| Antigens, CD | 4 | 2019 | 4001 | 0.070 |
Why?
|
| Alzheimer Disease | 2 | 2022 | 8601 | 0.070 |
Why?
|
| Genes | 1 | 2010 | 1823 | 0.070 |
Why?
|
| Prognosis | 5 | 2022 | 29629 | 0.070 |
Why?
|
| Brain | 4 | 2022 | 27121 | 0.070 |
Why?
|
| Pulmonary Surfactants | 1 | 2006 | 162 | 0.070 |
Why?
|
| Immunoglobulins | 2 | 2021 | 852 | 0.070 |
Why?
|
| Transforming Growth Factor beta | 3 | 2018 | 1964 | 0.070 |
Why?
|
| Caenorhabditis elegans Proteins | 2 | 2013 | 874 | 0.070 |
Why?
|
| Repressor Proteins | 4 | 2024 | 2986 | 0.070 |
Why?
|
| Ligands | 2 | 2018 | 3272 | 0.060 |
Why?
|
| Abdominal Pain | 1 | 2012 | 1071 | 0.060 |
Why?
|
| Vagina | 2 | 2023 | 838 | 0.060 |
Why?
|
| Transfection | 5 | 2008 | 5774 | 0.060 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 1992 | 874 | 0.060 |
Why?
|
| Benzylamines | 1 | 2006 | 247 | 0.060 |
Why?
|
| Immunoblotting | 5 | 2009 | 1646 | 0.060 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2006 | 817 | 0.060 |
Why?
|
| Insulin Resistance | 1 | 2019 | 3964 | 0.060 |
Why?
|
| Natural Killer T-Cells | 1 | 2009 | 322 | 0.060 |
Why?
|
| Dendrites | 1 | 2008 | 475 | 0.060 |
Why?
|
| Proteoglycans | 2 | 2022 | 803 | 0.060 |
Why?
|
| Drug Screening Assays, Antitumor | 3 | 2013 | 718 | 0.060 |
Why?
|
| Cullin Proteins | 2 | 2019 | 179 | 0.060 |
Why?
|
| Microarray Analysis | 3 | 2015 | 750 | 0.060 |
Why?
|
| Wiskott-Aldrich Syndrome Protein Family | 1 | 2004 | 35 | 0.060 |
Why?
|
| Escherichia | 1 | 2024 | 7 | 0.060 |
Why?
|
| Diet, Gluten-Free | 2 | 2018 | 283 | 0.060 |
Why?
|
| Gluconates | 1 | 2024 | 31 | 0.060 |
Why?
|
| MicroRNAs | 2 | 2012 | 3816 | 0.060 |
Why?
|
| Respiratory Mucosa | 1 | 2008 | 439 | 0.060 |
Why?
|
| Energy Transfer | 1 | 2005 | 108 | 0.060 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2006 | 302 | 0.060 |
Why?
|
| Metaphor | 1 | 2005 | 41 | 0.060 |
Why?
|
| Thiazolidines | 1 | 2004 | 69 | 0.060 |
Why?
|
| Spectrophotometry, Infrared | 1 | 2005 | 117 | 0.060 |
Why?
|
| DNA Primers | 3 | 2014 | 2820 | 0.060 |
Why?
|
| Integrases | 3 | 2013 | 518 | 0.060 |
Why?
|
| Skin | 3 | 2018 | 4484 | 0.060 |
Why?
|
| Depressive Disorder, Major | 1 | 2022 | 4761 | 0.060 |
Why?
|
| ROC Curve | 3 | 2018 | 3578 | 0.060 |
Why?
|
| Chromosome Aberrations | 1 | 2011 | 1768 | 0.060 |
Why?
|
| Hydrogen Bonding | 1 | 2005 | 291 | 0.060 |
Why?
|
| Acoustic Stimulation | 1 | 2009 | 1235 | 0.060 |
Why?
|
| Antigen-Presenting Cells | 1 | 2008 | 964 | 0.060 |
Why?
|
| Bronchi | 1 | 2008 | 845 | 0.060 |
Why?
|
| Carcinogens | 1 | 2006 | 452 | 0.060 |
Why?
|
| Superantigens | 1 | 2004 | 126 | 0.060 |
Why?
|
| Acetylgalactosamine | 1 | 2024 | 38 | 0.060 |
Why?
|
| Sensory Receptor Cells | 1 | 2009 | 513 | 0.060 |
Why?
|
| Ureter | 1 | 2006 | 368 | 0.060 |
Why?
|
| Cell Adhesion | 2 | 2024 | 3088 | 0.060 |
Why?
|
| Toll-Like Receptor 6 | 1 | 2023 | 29 | 0.060 |
Why?
|
| Cell Lineage | 1 | 2013 | 2557 | 0.060 |
Why?
|
| Captan | 1 | 2023 | 4 | 0.060 |
Why?
|
| Presenilin-1 | 1 | 2008 | 660 | 0.060 |
Why?
|
| Societies, Medical | 1 | 2016 | 3905 | 0.060 |
Why?
|
| Actomyosin | 1 | 2024 | 109 | 0.060 |
Why?
|
| United States | 5 | 2019 | 72335 | 0.060 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2016 | 1651 | 0.060 |
Why?
|
| Pregnancy | 2 | 2022 | 29876 | 0.060 |
Why?
|
| Genetics, Population | 2 | 2019 | 937 | 0.060 |
Why?
|
| Lentivirus | 2 | 2018 | 508 | 0.060 |
Why?
|
| Receptors, Interleukin-7 | 2 | 2013 | 40 | 0.060 |
Why?
|
| Bone Neoplasms | 2 | 2012 | 2529 | 0.060 |
Why?
|
| Statistics, Nonparametric | 3 | 2014 | 2850 | 0.060 |
Why?
|
| Follow-Up Studies | 4 | 2023 | 39107 | 0.050 |
Why?
|
| Clostridium | 1 | 2023 | 100 | 0.050 |
Why?
|
| Lichen Planus | 1 | 2024 | 70 | 0.050 |
Why?
|
| Cotinine | 1 | 2024 | 206 | 0.050 |
Why?
|
| Immunosuppressive Agents | 1 | 2016 | 4176 | 0.050 |
Why?
|
| Reoperation | 1 | 2014 | 4303 | 0.050 |
Why?
|
| 25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 1 | 2023 | 58 | 0.050 |
Why?
|
| MAP Kinase Kinase 4 | 2 | 2006 | 149 | 0.050 |
Why?
|
| Luminescent Measurements | 1 | 2005 | 342 | 0.050 |
Why?
|
| Consensus Sequence | 1 | 2003 | 365 | 0.050 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2020 | 695 | 0.050 |
Why?
|
| Endocytosis | 1 | 2007 | 957 | 0.050 |
Why?
|
| beta Catenin | 1 | 2008 | 1040 | 0.050 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2013 | 2057 | 0.050 |
Why?
|
| Exocytosis | 2 | 2018 | 320 | 0.050 |
Why?
|
| Virus Internalization | 2 | 2022 | 497 | 0.050 |
Why?
|
| Polyubiquitin | 2 | 2016 | 68 | 0.050 |
Why?
|
| Thiazoles | 2 | 2014 | 1517 | 0.050 |
Why?
|
| Murine hepatitis virus | 1 | 2022 | 19 | 0.050 |
Why?
|
| Putrescine | 1 | 2022 | 42 | 0.050 |
Why?
|
| Bone Density | 3 | 2008 | 3551 | 0.050 |
Why?
|
| Centrosome | 1 | 2024 | 209 | 0.050 |
Why?
|
| Interferon-alpha | 2 | 2011 | 921 | 0.050 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2006 | 1693 | 0.050 |
Why?
|
| Ornithine | 1 | 2022 | 79 | 0.050 |
Why?
|
| Hospitalization | 3 | 2019 | 10721 | 0.050 |
Why?
|
| Ornithine Decarboxylase | 1 | 2022 | 63 | 0.050 |
Why?
|
| Vibration | 1 | 2005 | 328 | 0.050 |
Why?
|
| Serine | 1 | 2006 | 831 | 0.050 |
Why?
|
| Enterococcus | 1 | 2023 | 159 | 0.050 |
Why?
|
| Spondylitis, Ankylosing | 1 | 2024 | 155 | 0.050 |
Why?
|
| rab GTP-Binding Proteins | 2 | 2018 | 250 | 0.050 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2003 | 286 | 0.050 |
Why?
|
| Bacterial Secretion Systems | 1 | 2022 | 37 | 0.050 |
Why?
|
| Lymphocyte Subsets | 2 | 2016 | 309 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2017 | 14665 | 0.050 |
Why?
|
| Glucose-6-Phosphate | 1 | 2021 | 29 | 0.050 |
Why?
|
| Caspase 1 | 2 | 2013 | 225 | 0.050 |
Why?
|
| Butyrate Response Factor 1 | 1 | 2021 | 10 | 0.050 |
Why?
|
| Histidine Decarboxylase | 1 | 2001 | 12 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 4 | 2008 | 6132 | 0.050 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2014 | 2223 | 0.050 |
Why?
|
| Calcium | 4 | 2023 | 5722 | 0.050 |
Why?
|
| Glucose-6-Phosphatase | 1 | 2021 | 72 | 0.050 |
Why?
|
| Interleukin-11 | 1 | 2022 | 58 | 0.050 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2006 | 2748 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase Phosphatases | 1 | 2021 | 47 | 0.050 |
Why?
|
| Sodium Dodecyl Sulfate | 1 | 2022 | 125 | 0.050 |
Why?
|
| Cholestenone 5 alpha-Reductase | 1 | 2021 | 21 | 0.050 |
Why?
|
| 3-Hydroxysteroid Dehydrogenases | 1 | 2021 | 34 | 0.050 |
Why?
|
| Dual-Specificity Phosphatases | 1 | 2021 | 71 | 0.050 |
Why?
|
| Chromosome Mapping | 3 | 2016 | 4615 | 0.050 |
Why?
|
| Mannose | 1 | 2022 | 121 | 0.050 |
Why?
|
| Peptide Fragments | 2 | 2013 | 5112 | 0.050 |
Why?
|
| Neuroendocrine Tumors | 1 | 2008 | 641 | 0.050 |
Why?
|
| Risk Assessment | 4 | 2017 | 23996 | 0.050 |
Why?
|
| Cyclophilins | 1 | 2021 | 48 | 0.050 |
Why?
|
| Classification | 1 | 2021 | 127 | 0.050 |
Why?
|
| Insulin | 2 | 2019 | 6597 | 0.050 |
Why?
|
| Treatment Failure | 2 | 2018 | 2644 | 0.050 |
Why?
|
| Class III Phosphatidylinositol 3-Kinases | 1 | 2020 | 17 | 0.050 |
Why?
|
| Predictive Value of Tests | 3 | 2020 | 15266 | 0.050 |
Why?
|
| Thiophenes | 2 | 2019 | 569 | 0.050 |
Why?
|
| Paired Box Transcription Factors | 1 | 2021 | 206 | 0.050 |
Why?
|
| Endoplasmic Reticulum, Rough | 1 | 2020 | 21 | 0.050 |
Why?
|
| Spine | 1 | 2008 | 1118 | 0.050 |
Why?
|
| Mucus | 2 | 2016 | 341 | 0.050 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2003 | 347 | 0.050 |
Why?
|
| Antineoplastic Agents | 3 | 2014 | 13642 | 0.050 |
Why?
|
| Nitric Oxide Synthase | 1 | 2004 | 908 | 0.050 |
Why?
|
| Weight Loss | 1 | 2012 | 2684 | 0.050 |
Why?
|
| STAT Transcription Factors | 1 | 2021 | 188 | 0.050 |
Why?
|
| Rectum | 2 | 2019 | 892 | 0.050 |
Why?
|
| Exercise | 1 | 2017 | 5890 | 0.040 |
Why?
|
| Sleep | 1 | 2016 | 4768 | 0.040 |
Why?
|
| Heart | 1 | 2014 | 4404 | 0.040 |
Why?
|
| Seasons | 2 | 2016 | 1520 | 0.040 |
Why?
|
| Databases, Genetic | 3 | 2015 | 1742 | 0.040 |
Why?
|
| Chemokines, CX3C | 1 | 2000 | 12 | 0.040 |
Why?
|
| Chemotaxis | 2 | 2016 | 598 | 0.040 |
Why?
|
| Gram-Positive Bacteria | 1 | 2021 | 177 | 0.040 |
Why?
|
| Cholic Acid | 1 | 2020 | 31 | 0.040 |
Why?
|
| Antiporters | 1 | 2021 | 277 | 0.040 |
Why?
|
| Host Specificity | 1 | 2020 | 57 | 0.040 |
Why?
|
| Biomedical Research | 1 | 2016 | 3429 | 0.040 |
Why?
|
| Bacterial Vaccines | 1 | 2022 | 401 | 0.040 |
Why?
|
| Receptors, Interleukin-17 | 1 | 2020 | 82 | 0.040 |
Why?
|
| Brain Ischemia | 1 | 2013 | 3049 | 0.040 |
Why?
|
| Endothelium, Lymphatic | 1 | 2000 | 63 | 0.040 |
Why?
|
| Immunohistochemistry | 3 | 2009 | 11076 | 0.040 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2021 | 436 | 0.040 |
Why?
|
| Indomethacin | 1 | 2000 | 325 | 0.040 |
Why?
|
| Nitric Oxide Synthase Type II | 3 | 2006 | 517 | 0.040 |
Why?
|
| STAT3 Transcription Factor | 3 | 2013 | 871 | 0.040 |
Why?
|
| MAP Kinase Signaling System | 3 | 2017 | 1486 | 0.040 |
Why?
|
| Caveolins | 1 | 2000 | 102 | 0.040 |
Why?
|
| Penetrance | 1 | 2021 | 383 | 0.040 |
Why?
|
| Arachidonic Acid | 1 | 2021 | 427 | 0.040 |
Why?
|
| Massachusetts | 3 | 2018 | 8830 | 0.040 |
Why?
|
| Lactic Acid | 2 | 2016 | 1139 | 0.040 |
Why?
|
| Enterococcus faecalis | 1 | 2020 | 245 | 0.040 |
Why?
|
| Quality of Life | 2 | 2023 | 13367 | 0.040 |
Why?
|
| DiGeorge Syndrome | 1 | 2001 | 185 | 0.040 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2002 | 585 | 0.040 |
Why?
|
| Leukocyte Count | 2 | 2019 | 1596 | 0.040 |
Why?
|
| Multivesicular Bodies | 1 | 2018 | 11 | 0.040 |
Why?
|
| Lung Neoplasms | 2 | 2014 | 13382 | 0.040 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2001 | 439 | 0.040 |
Why?
|
| Bone Diseases | 2 | 2008 | 418 | 0.040 |
Why?
|
| Oxidants | 1 | 2019 | 169 | 0.040 |
Why?
|
| Ubiquitins | 1 | 2000 | 366 | 0.040 |
Why?
|
| Thymus Gland | 3 | 2013 | 1243 | 0.040 |
Why?
|
| Animals, Newborn | 3 | 2011 | 2677 | 0.040 |
Why?
|
| Thrombospondins | 1 | 2019 | 194 | 0.040 |
Why?
|
| Drosophila | 1 | 2006 | 1495 | 0.040 |
Why?
|
| Drug Discovery | 2 | 2018 | 1051 | 0.040 |
Why?
|
| Hemolysin Proteins | 1 | 2018 | 113 | 0.040 |
Why?
|
| Alanine | 1 | 2021 | 609 | 0.040 |
Why?
|
| Ubiquitin-Protein Ligase Complexes | 1 | 2019 | 170 | 0.040 |
Why?
|
| Integrin alpha Chains | 1 | 2019 | 95 | 0.040 |
Why?
|
| Neovascularization, Pathologic | 1 | 2009 | 2645 | 0.040 |
Why?
|
| Genes, Regulator | 1 | 2019 | 373 | 0.040 |
Why?
|
| Pets | 1 | 2018 | 46 | 0.040 |
Why?
|
| Synapses | 1 | 2008 | 1769 | 0.040 |
Why?
|
| Demography | 2 | 2014 | 1648 | 0.040 |
Why?
|
| Chemokines, CXC | 1 | 2000 | 422 | 0.040 |
Why?
|
| T-Box Domain Proteins | 1 | 2001 | 469 | 0.040 |
Why?
|
| Cross-Sectional Studies | 4 | 2023 | 26127 | 0.040 |
Why?
|
| Circadian Clocks | 1 | 2020 | 164 | 0.040 |
Why?
|
| RNA, Neoplasm | 2 | 2013 | 750 | 0.040 |
Why?
|
| Collagenases | 1 | 2018 | 222 | 0.040 |
Why?
|
| Edetic Acid | 1 | 2018 | 276 | 0.040 |
Why?
|
| Coculture Techniques | 2 | 2013 | 1341 | 0.040 |
Why?
|
| Zebrafish | 3 | 2017 | 3007 | 0.040 |
Why?
|
| Arthritis | 2 | 2016 | 680 | 0.040 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2016 | 1321 | 0.040 |
Why?
|
| Plasma | 1 | 2021 | 586 | 0.040 |
Why?
|
| Protein Kinase C-epsilon | 1 | 2017 | 43 | 0.040 |
Why?
|
| Respiratory Insufficiency | 1 | 2006 | 1230 | 0.040 |
Why?
|
| Circoviridae | 1 | 2017 | 3 | 0.040 |
Why?
|
| Endosomes | 1 | 2020 | 522 | 0.040 |
Why?
|
| DNA, Ribosomal | 1 | 2019 | 300 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2019 | 3605 | 0.040 |
Why?
|
| Chromatin | 2 | 2021 | 2961 | 0.040 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2024 | 2510 | 0.040 |
Why?
|
| Wasting Syndrome | 1 | 2018 | 99 | 0.040 |
Why?
|
| Neoplasm Transplantation | 2 | 2013 | 2016 | 0.040 |
Why?
|
| Cell Respiration | 1 | 2018 | 201 | 0.040 |
Why?
|
| Prevalence | 3 | 2020 | 15732 | 0.040 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2022 | 829 | 0.040 |
Why?
|
| IgA Deficiency | 1 | 2017 | 39 | 0.040 |
Why?
|
| Growth Substances | 1 | 1999 | 768 | 0.040 |
Why?
|
| Neuroimmunomodulation | 1 | 2019 | 182 | 0.040 |
Why?
|
| Open Reading Frames | 1 | 2020 | 815 | 0.040 |
Why?
|
| Phosphate-Binding Proteins | 1 | 2018 | 93 | 0.040 |
Why?
|
| Injections, Intradermal | 1 | 2017 | 116 | 0.040 |
Why?
|
| Neoplasms, Experimental | 2 | 2013 | 1229 | 0.040 |
Why?
|
| Minor Histocompatibility Antigens | 2 | 2009 | 293 | 0.040 |
Why?
|
| Dengue Virus | 2 | 2009 | 201 | 0.040 |
Why?
|
| Mammary Neoplasms, Experimental | 2 | 1998 | 507 | 0.040 |
Why?
|
| France | 1 | 2018 | 497 | 0.040 |
Why?
|
| Carbonyl Cyanide m-Chlorophenyl Hydrazone | 1 | 2016 | 22 | 0.040 |
Why?
|
| Ribosomes | 1 | 2020 | 501 | 0.030 |
Why?
|
| Radiotherapy | 1 | 2004 | 1499 | 0.030 |
Why?
|
| Myosin Type I | 1 | 2016 | 23 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 2 | 2012 | 1705 | 0.030 |
Why?
|
| Malonates | 1 | 2016 | 43 | 0.030 |
Why?
|
| Tumor Burden | 2 | 2013 | 1893 | 0.030 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2016 | 41 | 0.030 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2022 | 1007 | 0.030 |
Why?
|
| STAT6 Transcription Factor | 1 | 2017 | 194 | 0.030 |
Why?
|
| Paracoccidioidomycosis | 1 | 1996 | 10 | 0.030 |
Why?
|
| Immunogenetic Phenomena | 1 | 2016 | 23 | 0.030 |
Why?
|
| Borrelia burgdorferi Group | 1 | 2016 | 97 | 0.030 |
Why?
|
| Sulfonamides | 1 | 2006 | 1978 | 0.030 |
Why?
|
| Random Allocation | 1 | 2021 | 2395 | 0.030 |
Why?
|
| Computer Simulation | 2 | 2024 | 6241 | 0.030 |
Why?
|
| Reoviridae | 1 | 2017 | 162 | 0.030 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2017 | 112 | 0.030 |
Why?
|
| Cancer Vaccines | 1 | 2024 | 1051 | 0.030 |
Why?
|
| Rats | 4 | 2013 | 23741 | 0.030 |
Why?
|
| Chromogranin A | 1 | 2016 | 49 | 0.030 |
Why?
|
| New Zealand | 1 | 2017 | 358 | 0.030 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2016 | 126 | 0.030 |
Why?
|
| Interleukin-8 | 1 | 2019 | 696 | 0.030 |
Why?
|
| Antigens, Neoplasm | 1 | 2024 | 1993 | 0.030 |
Why?
|
| Chlorpromazine | 1 | 2016 | 111 | 0.030 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2022 | 1141 | 0.030 |
Why?
|
| Embolism, Cholesterol | 1 | 1995 | 32 | 0.030 |
Why?
|
| Endothelial Growth Factors | 1 | 1998 | 673 | 0.030 |
Why?
|
| Prostaglandin D2 | 1 | 2016 | 108 | 0.030 |
Why?
|
| Intention to Treat Analysis | 1 | 2017 | 413 | 0.030 |
Why?
|
| Vomiting | 1 | 2019 | 651 | 0.030 |
Why?
|
| Molecular Epidemiology | 1 | 2018 | 469 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 2019 | 730 | 0.030 |
Why?
|
| Enzyme Precursors | 1 | 1996 | 170 | 0.030 |
Why?
|
| Biopsy | 2 | 2018 | 6766 | 0.030 |
Why?
|
| Cytoplasm | 1 | 2000 | 1510 | 0.030 |
Why?
|
| Testis | 1 | 2019 | 794 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 2 | 2011 | 1612 | 0.030 |
Why?
|
| Integrin beta3 | 1 | 2016 | 120 | 0.030 |
Why?
|
| Diarrhea | 1 | 2022 | 1318 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 3 | 2012 | 6075 | 0.030 |
Why?
|
| Glutamic Acid | 1 | 2021 | 1176 | 0.030 |
Why?
|
| Proto-Oncogenes | 1 | 1996 | 321 | 0.030 |
Why?
|
| Lymphokines | 1 | 1998 | 927 | 0.030 |
Why?
|
| Enteroendocrine Cells | 1 | 2016 | 78 | 0.030 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2016 | 295 | 0.030 |
Why?
|
| Citric Acid Cycle | 1 | 2016 | 231 | 0.030 |
Why?
|
| Puberty | 1 | 2018 | 501 | 0.030 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2020 | 858 | 0.030 |
Why?
|
| Interferons | 2 | 2009 | 706 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 1998 | 641 | 0.030 |
Why?
|
| Placebo Effect | 1 | 2019 | 518 | 0.030 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2011 | 3763 | 0.030 |
Why?
|
| Skin Diseases | 1 | 2024 | 1094 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2023 | 2330 | 0.030 |
Why?
|
| Dopamine Antagonists | 1 | 2016 | 288 | 0.030 |
Why?
|
| Genetic Pleiotropy | 1 | 2016 | 181 | 0.030 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2016 | 436 | 0.030 |
Why?
|
| Antioxidants | 1 | 2023 | 1668 | 0.030 |
Why?
|
| Gentamicins | 1 | 2016 | 243 | 0.030 |
Why?
|
| Enzyme Activators | 1 | 2015 | 57 | 0.030 |
Why?
|
| Pyroglyphidae | 1 | 2015 | 89 | 0.030 |
Why?
|
| RANK Ligand | 1 | 2016 | 318 | 0.030 |
Why?
|
| Virulence | 1 | 2018 | 1303 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 1 | 2014 | 110 | 0.030 |
Why?
|
| Vacuoles | 1 | 2015 | 228 | 0.030 |
Why?
|
| Administration, Intravesical | 1 | 2014 | 92 | 0.030 |
Why?
|
| Aerobiosis | 1 | 2014 | 100 | 0.030 |
Why?
|
| Fruit | 1 | 2020 | 1160 | 0.030 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2017 | 504 | 0.030 |
Why?
|
| Viremia | 1 | 2018 | 707 | 0.030 |
Why?
|
| Enteral Nutrition | 1 | 2021 | 794 | 0.030 |
Why?
|
| HIV-1 | 2 | 2013 | 6863 | 0.030 |
Why?
|
| Individuality | 1 | 2016 | 301 | 0.030 |
Why?
|
| Mammary Glands, Animal | 1 | 1996 | 273 | 0.030 |
Why?
|
| Chromosomes, Human | 1 | 2016 | 441 | 0.030 |
Why?
|
| Neuroglia | 1 | 2020 | 956 | 0.030 |
Why?
|
| Ferritins | 1 | 2017 | 598 | 0.030 |
Why?
|
| Meta-Analysis as Topic | 2 | 2010 | 1380 | 0.030 |
Why?
|
| Donor Selection | 1 | 2016 | 232 | 0.030 |
Why?
|
| Selection, Genetic | 1 | 2019 | 868 | 0.030 |
Why?
|
| Boston | 2 | 2018 | 9326 | 0.030 |
Why?
|
| Siblings | 1 | 2018 | 825 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2022 | 4021 | 0.030 |
Why?
|
| Oxidative Phosphorylation | 1 | 2016 | 496 | 0.030 |
Why?
|
| Adiponectin | 1 | 2020 | 1113 | 0.030 |
Why?
|
| Pyridazines | 1 | 2016 | 202 | 0.030 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2013 | 5315 | 0.030 |
Why?
|
| Interleukin-4 | 1 | 2018 | 1149 | 0.030 |
Why?
|
| Twins, Monozygotic | 1 | 2016 | 470 | 0.030 |
Why?
|
| Plant Proteins | 1 | 2016 | 370 | 0.030 |
Why?
|
| Cardiac Glycosides | 1 | 2013 | 29 | 0.030 |
Why?
|
| Mice, Nude | 2 | 2012 | 3614 | 0.030 |
Why?
|
| Double-Blind Method | 2 | 2019 | 12341 | 0.030 |
Why?
|
| Forecasting | 1 | 2023 | 2928 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2016 | 638 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2017 | 20569 | 0.030 |
Why?
|
| Vancomycin | 1 | 2017 | 503 | 0.030 |
Why?
|
| Caspase 3 | 1 | 2016 | 731 | 0.030 |
Why?
|
| Type C Phospholipases | 1 | 2014 | 287 | 0.030 |
Why?
|
| Deoxyribonuclease I | 1 | 2014 | 224 | 0.030 |
Why?
|
| Infarction | 1 | 1995 | 248 | 0.030 |
Why?
|
| Histological Techniques | 1 | 2014 | 194 | 0.030 |
Why?
|
| Hematopoiesis | 1 | 2023 | 2050 | 0.030 |
Why?
|
| Cell Degranulation | 1 | 2014 | 277 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2014 | 6484 | 0.030 |
Why?
|
| Endoscopy, Digestive System | 1 | 2016 | 351 | 0.030 |
Why?
|
| Delivery, Obstetric | 1 | 2020 | 940 | 0.030 |
Why?
|
| Cell Separation | 2 | 2010 | 1720 | 0.030 |
Why?
|
| Chemokine CXCL10 | 1 | 2014 | 316 | 0.030 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2019 | 1133 | 0.030 |
Why?
|
| Immunity, Active | 1 | 2013 | 58 | 0.030 |
Why?
|
| Dogs | 1 | 1998 | 3839 | 0.030 |
Why?
|
| Intestinal Obstruction | 1 | 2017 | 432 | 0.030 |
Why?
|
| Saliva | 1 | 2017 | 828 | 0.030 |
Why?
|
| Bacterial Toxins | 1 | 2018 | 932 | 0.030 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2018 | 774 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2013 | 2918 | 0.030 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 1 | 2013 | 119 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2013 | 126 | 0.030 |
Why?
|
| Homozygote | 2 | 2008 | 1776 | 0.030 |
Why?
|
| nef Gene Products, Human Immunodeficiency Virus | 1 | 2013 | 148 | 0.030 |
Why?
|
| Fatigue | 1 | 2020 | 1552 | 0.030 |
Why?
|
| Cross Reactions | 1 | 2014 | 817 | 0.030 |
Why?
|
| Uveitis | 1 | 2016 | 395 | 0.030 |
Why?
|
| Morbidity | 1 | 2018 | 1751 | 0.030 |
Why?
|
| Genes, APC | 1 | 2013 | 145 | 0.030 |
Why?
|
| Interleukin-2 | 1 | 2019 | 1889 | 0.030 |
Why?
|
| Indenes | 1 | 2013 | 59 | 0.030 |
Why?
|
| Chikungunya virus | 1 | 2013 | 56 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2016 | 1541 | 0.030 |
Why?
|
| Genes, rRNA | 1 | 2012 | 74 | 0.030 |
Why?
|
| Urinary Bladder | 1 | 2018 | 1152 | 0.030 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2019 | 1349 | 0.030 |
Why?
|
| Joint Diseases | 1 | 1996 | 459 | 0.030 |
Why?
|
| Linkage Disequilibrium | 1 | 2017 | 1998 | 0.030 |
Why?
|
| NF-kappa B p52 Subunit | 1 | 2012 | 35 | 0.020 |
Why?
|
| Sindbis Virus | 1 | 2011 | 36 | 0.020 |
Why?
|
| Zimbabwe | 1 | 1992 | 135 | 0.020 |
Why?
|
| Histocompatibility Antigens | 1 | 2013 | 464 | 0.020 |
Why?
|
| Mycobacterium Infections | 1 | 2012 | 122 | 0.020 |
Why?
|
| Chromones | 1 | 2012 | 148 | 0.020 |
Why?
|
| Heterozygote | 1 | 2019 | 2787 | 0.020 |
Why?
|
| Leptin | 1 | 2020 | 1597 | 0.020 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2016 | 386 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2012 | 205 | 0.020 |
Why?
|
| Receptors, OX40 | 1 | 2011 | 44 | 0.020 |
Why?
|
| Superoxides | 1 | 2013 | 387 | 0.020 |
Why?
|
| Cytosine | 1 | 2013 | 211 | 0.020 |
Why?
|
| Lipolysis | 1 | 2013 | 212 | 0.020 |
Why?
|
| Growth Inhibitors | 1 | 2013 | 378 | 0.020 |
Why?
|
| Cadaver | 1 | 2016 | 1358 | 0.020 |
Why?
|
| Liver Regeneration | 1 | 2013 | 213 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2020 | 2020 | 0.020 |
Why?
|
| Interleukin-18 | 1 | 2013 | 250 | 0.020 |
Why?
|
| Radiation Chimera | 1 | 2011 | 216 | 0.020 |
Why?
|
| Glycosphingolipids | 1 | 2011 | 73 | 0.020 |
Why?
|
| International Cooperation | 1 | 2017 | 1422 | 0.020 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2015 | 579 | 0.020 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2016 | 572 | 0.020 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 2011 | 141 | 0.020 |
Why?
|
| Phenylurea Compounds | 1 | 2014 | 529 | 0.020 |
Why?
|
| Androstadienes | 1 | 2013 | 348 | 0.020 |
Why?
|
| Neoadjuvant Therapy | 1 | 2022 | 2827 | 0.020 |
Why?
|
| Carbohydrate Metabolism | 1 | 2012 | 263 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2021 | 5439 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2017 | 2079 | 0.020 |
Why?
|
| Sphingosine | 1 | 2013 | 308 | 0.020 |
Why?
|
| Lipase | 1 | 2013 | 325 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2014 | 727 | 0.020 |
Why?
|
| Mitochondrial Proteins | 1 | 2016 | 976 | 0.020 |
Why?
|
| Cystic Fibrosis | 1 | 2020 | 1285 | 0.020 |
Why?
|
| Mentors | 1 | 2016 | 661 | 0.020 |
Why?
|
| Genes, p53 | 1 | 2013 | 712 | 0.020 |
Why?
|
| Macromolecular Substances | 2 | 2004 | 1434 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2007 | 687 | 0.020 |
Why?
|
| Angiography | 1 | 1995 | 1595 | 0.020 |
Why?
|
| Sacrum | 1 | 2012 | 276 | 0.020 |
Why?
|
| Peroxidase | 2 | 2004 | 609 | 0.020 |
Why?
|
| Dioxoles | 1 | 2010 | 95 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2012 | 506 | 0.020 |
Why?
|
| Tetrahydroisoquinolines | 1 | 2010 | 81 | 0.020 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2013 | 370 | 0.020 |
Why?
|
| Imidazoles | 1 | 2016 | 1180 | 0.020 |
Why?
|
| Survival Analysis | 2 | 2013 | 10090 | 0.020 |
Why?
|
| Immunoglobulin G | 2 | 2019 | 4544 | 0.020 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2011 | 473 | 0.020 |
Why?
|
| Nervous System Diseases | 1 | 2020 | 1667 | 0.020 |
Why?
|
| History, 21st Century | 1 | 2016 | 1567 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2012 | 855 | 0.020 |
Why?
|
| Renal Insufficiency | 1 | 1995 | 809 | 0.020 |
Why?
|
| Methylation | 1 | 2012 | 1084 | 0.020 |
Why?
|
| Indicators and Reagents | 2 | 2002 | 462 | 0.020 |
Why?
|
| Vimentin | 1 | 2010 | 255 | 0.020 |
Why?
|
| Furans | 1 | 2010 | 202 | 0.020 |
Why?
|
| Virulence Factors | 1 | 2013 | 513 | 0.020 |
Why?
|
| Nicotine | 1 | 2014 | 680 | 0.020 |
Why?
|
| Propensity Score | 1 | 2017 | 1913 | 0.020 |
Why?
|
| Coat Protein Complex I | 1 | 2009 | 37 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2019 | 2161 | 0.020 |
Why?
|
| Nitriles | 1 | 2014 | 971 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2013 | 1757 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2013 | 2180 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2017 | 4853 | 0.020 |
Why?
|
| Aniline Compounds | 1 | 2014 | 1069 | 0.020 |
Why?
|
| Cholesterol, HDL | 1 | 2015 | 1814 | 0.020 |
Why?
|
| Quinolines | 1 | 2014 | 765 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2001 | 3060 | 0.020 |
Why?
|
| Sendai virus | 1 | 2008 | 22 | 0.020 |
Why?
|
| Morpholines | 1 | 2012 | 581 | 0.020 |
Why?
|
| Flavonoids | 1 | 2012 | 445 | 0.020 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 1996 | 1626 | 0.020 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2014 | 819 | 0.020 |
Why?
|
| Keratins | 1 | 2010 | 498 | 0.020 |
Why?
|
| Viral Proteins | 2 | 2009 | 1804 | 0.020 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2012 | 1351 | 0.020 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2008 | 80 | 0.020 |
Why?
|
| Vesiculovirus | 1 | 2008 | 55 | 0.020 |
Why?
|
| Immunotherapy | 1 | 2024 | 4651 | 0.020 |
Why?
|
| Capsid Proteins | 1 | 2011 | 468 | 0.020 |
Why?
|
| Bone Marrow | 2 | 1995 | 2911 | 0.020 |
Why?
|
| Acetates | 1 | 2009 | 321 | 0.020 |
Why?
|
| Tissue Donors | 1 | 2018 | 2332 | 0.020 |
Why?
|
| Canada | 1 | 2013 | 2122 | 0.020 |
Why?
|
| Human Immunodeficiency Virus Proteins | 1 | 2008 | 59 | 0.020 |
Why?
|
| History, 20th Century | 1 | 2016 | 2767 | 0.020 |
Why?
|
| Protein Array Analysis | 1 | 2009 | 400 | 0.020 |
Why?
|
| Melanoma, Experimental | 1 | 2011 | 561 | 0.020 |
Why?
|
| Triglycerides | 1 | 2015 | 2461 | 0.020 |
Why?
|
| Kidney | 1 | 2023 | 7048 | 0.020 |
Why?
|
| Retrospective Studies | 5 | 2016 | 80646 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2011 | 1900 | 0.020 |
Why?
|
| Genetic Linkage | 1 | 2013 | 2341 | 0.020 |
Why?
|
| Mediator Complex | 1 | 2008 | 106 | 0.020 |
Why?
|
| Zebrafish Proteins | 1 | 2014 | 1014 | 0.020 |
Why?
|
| Vero Cells | 1 | 2008 | 482 | 0.020 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2008 | 190 | 0.020 |
Why?
|
| Karyopherins | 1 | 2008 | 133 | 0.020 |
Why?
|
| Mutagenesis | 1 | 2011 | 1232 | 0.020 |
Why?
|
| Interleukin-1 | 2 | 2002 | 1248 | 0.020 |
Why?
|
| Adenine | 1 | 2013 | 987 | 0.020 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2008 | 242 | 0.020 |
Why?
|
| Dimerization | 1 | 2008 | 891 | 0.020 |
Why?
|
| I-kappa B Kinase | 1 | 2008 | 250 | 0.020 |
Why?
|
| Immunogenetics | 1 | 2007 | 62 | 0.020 |
Why?
|
| Nod1 Signaling Adaptor Protein | 1 | 2006 | 12 | 0.020 |
Why?
|
| Parents | 1 | 2021 | 3563 | 0.020 |
Why?
|
| DNA Repair | 1 | 2016 | 2046 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2012 | 2626 | 0.020 |
Why?
|
| Antigens, Differentiation | 1 | 2009 | 909 | 0.020 |
Why?
|
| Transcription Factor AP-1 | 1 | 2008 | 321 | 0.020 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2016 | 1841 | 0.020 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2009 | 353 | 0.020 |
Why?
|
| RNA Splicing | 1 | 2011 | 918 | 0.020 |
Why?
|
| Trinitrobenzenesulfonic Acid | 1 | 2006 | 64 | 0.020 |
Why?
|
| Receptors, IgG | 1 | 2010 | 559 | 0.020 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2009 | 435 | 0.020 |
Why?
|
| Fasting | 1 | 2013 | 1603 | 0.020 |
Why?
|
| Leadership | 1 | 2016 | 1385 | 0.020 |
Why?
|
| Erythrocytes | 1 | 1996 | 2413 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2008 | 411 | 0.020 |
Why?
|
| S Phase | 1 | 2007 | 421 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2008 | 477 | 0.020 |
Why?
|
| Influenza A virus | 1 | 2009 | 458 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2016 | 2639 | 0.020 |
Why?
|
| Hepatocytes | 1 | 2013 | 1233 | 0.020 |
Why?
|
| Hyperplasia | 2 | 2002 | 1152 | 0.020 |
Why?
|
| Cholesterol, LDL | 1 | 2015 | 2382 | 0.020 |
Why?
|
| Virus Integration | 1 | 2008 | 304 | 0.020 |
Why?
|
| Kinetics | 2 | 2008 | 6374 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 2457 | 0.020 |
Why?
|
| Staphylococcal Infections | 1 | 2014 | 1407 | 0.020 |
Why?
|
| GTP Phosphohydrolases | 1 | 2008 | 517 | 0.020 |
Why?
|
| Food | 1 | 2010 | 774 | 0.020 |
Why?
|
| Hydronephrosis | 1 | 2006 | 271 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2014 | 3396 | 0.010 |
Why?
|
| Inpatients | 1 | 2016 | 2548 | 0.010 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2008 | 545 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2018 | 8633 | 0.010 |
Why?
|
| Carcinoma, Neuroendocrine | 1 | 2008 | 339 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2006 | 597 | 0.010 |
Why?
|
| Education, Medical | 1 | 2016 | 1725 | 0.010 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2008 | 409 | 0.010 |
Why?
|
| Drug Delivery Systems | 1 | 1995 | 2226 | 0.010 |
Why?
|
| Cisplatin | 1 | 2010 | 1652 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2012 | 6228 | 0.010 |
Why?
|
| Leucine | 1 | 2005 | 548 | 0.010 |
Why?
|
| Multiprotein Complexes | 1 | 2010 | 1120 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2013 | 2827 | 0.010 |
Why?
|
| Apolipoproteins E | 1 | 2009 | 1443 | 0.010 |
Why?
|
| Polymers | 1 | 2010 | 1616 | 0.010 |
Why?
|
| Doxorubicin | 1 | 2010 | 2224 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2004 | 174 | 0.010 |
Why?
|
| Cell Division | 2 | 2003 | 4465 | 0.010 |
Why?
|
| Multienzyme Complexes | 1 | 2006 | 666 | 0.010 |
Why?
|
| Social Class | 1 | 1992 | 2004 | 0.010 |
Why?
|
| Phospholipids | 1 | 2006 | 786 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 2008 | 1206 | 0.010 |
Why?
|
| Length of Stay | 1 | 2016 | 6426 | 0.010 |
Why?
|
| Pyrazoles | 1 | 2013 | 2009 | 0.010 |
Why?
|
| Genes, T-Cell Receptor alpha | 1 | 2002 | 19 | 0.010 |
Why?
|
| Mass Screening | 1 | 2018 | 5428 | 0.010 |
Why?
|
| Pyrimidines | 1 | 2014 | 3028 | 0.010 |
Why?
|
| Smoking Cessation | 1 | 2014 | 2057 | 0.010 |
Why?
|
| Linear Models | 1 | 2012 | 5872 | 0.010 |
Why?
|
| Mice, Inbred DBA | 1 | 2003 | 621 | 0.010 |
Why?
|
| Terminator Regions, Genetic | 1 | 2001 | 26 | 0.010 |
Why?
|
| Gastrins | 1 | 2001 | 74 | 0.010 |
Why?
|
| Collagen | 1 | 2010 | 2638 | 0.010 |
Why?
|
| Anxiety | 1 | 2016 | 4573 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2006 | 1171 | 0.010 |
Why?
|
| Amantadine | 1 | 2001 | 57 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides, Antisense | 1 | 2001 | 58 | 0.010 |
Why?
|
| RNA, Catalytic | 1 | 2001 | 53 | 0.010 |
Why?
|
| Bromodeoxyuridine | 1 | 2002 | 311 | 0.010 |
Why?
|
| Antimetabolites | 1 | 2002 | 129 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2008 | 2112 | 0.010 |
Why?
|
| Genes, ras | 1 | 2004 | 654 | 0.010 |
Why?
|
| Histamine Antagonists | 1 | 2001 | 92 | 0.010 |
Why?
|
| Hepatitis C | 1 | 2011 | 1584 | 0.010 |
Why?
|
| HIV | 1 | 2008 | 1582 | 0.010 |
Why?
|
| HIV Infections | 1 | 2008 | 17352 | 0.010 |
Why?
|
| Genes, Synthetic | 1 | 2001 | 88 | 0.010 |
Why?
|
| Helminth Proteins | 1 | 2002 | 173 | 0.010 |
Why?
|
| Granulocytes | 1 | 2003 | 551 | 0.010 |
Why?
|
| Acute Disease | 1 | 2011 | 7237 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2004 | 705 | 0.010 |
Why?
|
| Calcitriol | 1 | 2002 | 296 | 0.010 |
Why?
|
| Enzymes | 1 | 2002 | 257 | 0.010 |
Why?
|
| Lumbosacral Region | 1 | 2002 | 293 | 0.010 |
Why?
|
| Sepsis | 1 | 2014 | 2585 | 0.010 |
Why?
|
| Mucin-3 | 1 | 1999 | 6 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 2002 | 1085 | 0.010 |
Why?
|
| Splenectomy | 1 | 2002 | 391 | 0.010 |
Why?
|
| Cardiac Surgical Procedures | 1 | 1995 | 3627 | 0.010 |
Why?
|
| Embryonic Stem Cells | 1 | 2007 | 1263 | 0.010 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2001 | 143 | 0.010 |
Why?
|
| Response Elements | 1 | 2001 | 309 | 0.010 |
Why?
|
| Fetus | 1 | 2007 | 1863 | 0.010 |
Why?
|
| Chemokine CX3CL1 | 1 | 2000 | 63 | 0.010 |
Why?
|
| Bacteriophage T7 | 1 | 2001 | 174 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2001 | 346 | 0.010 |
Why?
|
| Acetic Acid | 1 | 1999 | 60 | 0.010 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2002 | 344 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2003 | 799 | 0.010 |
Why?
|
| Detergents | 1 | 2000 | 236 | 0.010 |
Why?
|
| Receptors, HIV | 1 | 2000 | 159 | 0.010 |
Why?
|
| Ribavirin | 1 | 2001 | 395 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2005 | 4174 | 0.010 |
Why?
|
| Glycolipids | 1 | 2000 | 206 | 0.010 |
Why?
|
| Receptors, Cytokine | 1 | 2000 | 258 | 0.010 |
Why?
|
| Parathyroid Glands | 1 | 2001 | 518 | 0.010 |
Why?
|
| Diphtheria Toxin | 1 | 1999 | 253 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 1999 | 574 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1999 | 698 | 0.010 |
Why?
|
| Gastritis | 1 | 2000 | 199 | 0.010 |
Why?
|
| Permeability | 1 | 2000 | 723 | 0.010 |
Why?
|
| Caveolin 1 | 1 | 2000 | 256 | 0.010 |
Why?
|
| Solubility | 1 | 2000 | 1091 | 0.010 |
Why?
|
| Software | 1 | 2012 | 4434 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2013 | 5305 | 0.010 |
Why?
|
| Gene Library | 1 | 2001 | 1059 | 0.010 |
Why?
|
| Gastric Mucosa | 1 | 2000 | 604 | 0.010 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2000 | 662 | 0.010 |
Why?
|
| Chimera | 1 | 1998 | 453 | 0.010 |
Why?
|
| Amyloid beta-Peptides | 1 | 2010 | 3839 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 1998 | 748 | 0.010 |
Why?
|
| Depression | 1 | 2016 | 8124 | 0.010 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 1998 | 441 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2014 | 9281 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 1998 | 837 | 0.010 |
Why?
|
| Lung Diseases, Fungal | 1 | 1996 | 126 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1998 | 2561 | 0.010 |
Why?
|
| Incidence | 1 | 1992 | 21355 | 0.010 |
Why?
|
| Sheep | 1 | 1996 | 1440 | 0.010 |
Why?
|
| RNA, Viral | 1 | 2001 | 2846 | 0.010 |
Why?
|
| Leukotrienes | 1 | 1993 | 231 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2002 | 2856 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2002 | 6312 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 1995 | 1972 | 0.010 |
Why?
|
| Rabbits | 1 | 1996 | 4772 | 0.010 |
Why?
|
| Tibia | 1 | 1995 | 1070 | 0.010 |
Why?
|
| Body Weight | 1 | 1999 | 4618 | 0.000 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2001 | 2297 | 0.000 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 1998 | 3492 | 0.000 |
Why?
|
| Liver Neoplasms | 1 | 2001 | 4317 | 0.000 |
Why?
|